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Atherosclerosis is characterized by chronic inflammation of the arterial wall through 
the accumulation of lipid-loaded macrophages. Cell death within this region causes 
the progression of the fatty streak into an advanced atherosclerotic lesion with a 
characteristic necrotic core, consisting of cholesterol, calcium deposits, dead cells and 
other cellular debris. The oxidation of low-density lipoprotein (LDL) to form oxidized 
LDL (oxLDL) is a crucial event in the development of the atherosclerotic lesion 
resulting in death to a range of cell types within the intima. OxLDL is cytotoxic to 
macrophages through a rapid induction of intracellular oxidative stress, resulting in 
oxidative damage to essential biomolecules causing cell death that contributes to the 
development of the necrotic core.  
 
This study investigated the source of the cytotoxic oxidative stress triggered by the 
presence of oxLDL in U937 monocyte like cells. The research investigated whether 
NADPH oxidase, myeloperoxidase or uncoupled mitochondria generated intracellular 
oxidants in response to oxLDL. 
 
Specific NOX inhibitors, (gp91ds-tat and apocynin), provided insight on the 
involvement of NOX in the oxLDL-induced oxidative stress mechanism. Increasing 
concentrations of gp91ds-tat significantly decreased intracellular superoxide 
generation in U937 cells but did not prevent cell viability loss. The competitive 
inhibitor, gp91ds-tat, did not completely inhibit the complex, allowing for residual 
superoxide to be generated. Apocynin treated plaque sections showed a significant 
reduction in 7,8-dihydroneopterin (7,8-NP) oxidation. This study also measured the 
U937 intracellular 7,8-NP oxidation by cellular oxidants in response to oxLDL. The 
addition of apocynin significant reduced the oxLDL-induced 7,8-NP oxidation. This 
suggested that NOX was the major source of intracellular oxidative stress in both in 
vivo and in vitro research. 
 
Myeloperoxidase was shown to not be involved in the in vitro mechanism, as 
inhibition of hypochlorite production through MPO inhibitors (ABAH & thiocyanate) 




U937 cells were incubated with oxLDL. This suggests that MPO is not involved in 
the U937 cell death mechanism as a result of oxLDL exposure. 
 
OxLDL induced a significant depolarization of the mitochondria membrane potential 
after 6 hours exposure and the addition of 7,8-NP did not protect the membrane 
depolarization. However, the data that was collected was deemed inconclusive due to 
fundamental problems occurring within the JC-1 assay.  
  
Our results suggest that NOX is the major source of oxidative stress causing 
significant cell death and progression of the plaque necrotic core. It was shown that 
myeloperoxidase has no involvement in the oxidative stress mechanism and that the 























1.1 Overview  
Atherosclerosis is a complex disease that results from the thickening of the arterial 
wall from a build-up of cellular debris and lipids to form a complex plaque that 
restricts the blood flow (Libby 2002). Low-density lipoprotein (LDL) is a lipid-
carrying particle that distributes cholesterol, phospholipids and triglycerides around 
our body (Brown 1986). These particles can accumulate underneath the arterial wall, 
forming a fatty streak and promoting inflammation. Macrophages play an important 
role in the inflammatory process and are recruited to the site to resolve the 
inflammatory response initiated by trapped LDL. Macrophages release oxidants into 
the environment that can oxidize the LDL particles (Aviram 1996). The formation of 
oxidized LDL (oxLDL) is a significant driving factor in the disease, as it drives the 
transition of a fatty streak into an advanced complex plaque by initiating cell death to 
the immune cells present (Gieseg 2010 A). Death of the cell results in cell debris, 
cytokines and more oxidants to be released into the artery intima contributing to 
further inflammation and progression of a plaque. Eventually the necrotic core can 
rupture, releasing all of the trapped content into the artery and the formation of a 
blood clot causes a blockage downstream of the plaque, resulting in a heart attack or 
stroke (Libby 2002, Douglas 2014).  Acute oxLDL toxicity causes intracellular 
oxidative stress by an overproduction of oxidants in HMDM and U937 cells (Gieseg 
2010 B, Katouah 2015). Experimental research indicates that there is a strong 
relationship between an overproduction of intracellular oxidants and subsequent cell 
death as a result of oxLDL exposure (Chen 2012, Katouah 2015). It is currently 
unknown the source of intracellular oxidative stress, however, NADPH oxidase 
(NOX-2), mitochondria and myeloperoxidase are all known sites to produce oxidants. 
7,8-Dihydroneopterin (7,8-NP) is synthesized by activated macrophages at sites of 
inflammation, however, its cellular purpose is undetermined. 7,8-NP has been shown 
to protect cells against an oxLDL induced cell death and reduce the intracellular 
oxidative stress generated by oxLDL (Gieseg 2001 A, Chen 2012). Therefore this 
research will investigate the three possible sources of oxLDL-induced intracellular 





1. 2  Atherosclerosis 
1.2.1 Cardiovascular disease and atherosclerosis 
According to the World Health Organization (WHO), cardiovascular diseases (CVD) 
are the number one cause of death globally, accounting for approximately 30% of all 
global deaths (Santulli 2013). CVD includes coronary heart disease, strokes and 
peripheral vascular disease that all involve the underlying process of atherosclerosis.  
Atherosclerosis is a chronic inflammatory disease that involves endothelial 
dysfunction, inflammation of the arterial wall, immune cell recruitment and 
thickening of the arterial intima through a build-up of cellular debris, lipids, 
cholesterol and calcium deposition (Bobryshev 2006). Modifications to the arterial 
wall results in large occlusions called plaques that restrict the blood flow, causing 
abnormalities and reduced oxygen supply to essential organs. Progression of the 
atherosclerotic plaque makes the lesion unstable and vulnerable to rupturing. Plaque 
rupture releases the content into the blood stream triggering a thrombus (blood clot) 
formation, which lodges in smaller capillary beds, restricting or completely blocking 
the blood supply (Falk 1983). This can result in a myocardial or cerebral infarction 
(heart attack or stroke respectively) depending on the location of the plaque (Libby 
2002, Hansson 2011). There are a series of risk factors which influence the severity 
and likelihood of developing the disease, which include genetic predisposition, age, 
obesity, gender, cigarette smoking, physical inactivity, excessive alcohol 
consumption, hypertension, type II diabetes and hyperlipidemia (Meyer 2000, Libby 
2002). 
1.2.2 Initiation and progression of atherosclerosis 
The exact details on the initiation of atherosclerosis remain controversial, however, a 
number of theories have been proposed to explain the early stages of plaque 
formation.  
 
The response to injury hypothesis states that the lesion is formed through chronic 
injury occurring to the arterial endothelial layer at a branched point in the artery due 
to high blood pressure or mechanical shear stress. These events promote an 
inflammatory cascade to recruit leukocytes to the area of inflammation, to resolve the 




to the inflamed endothelium.  As a result of the damaged endothelial layer, Low-
Density Lipoprotein (LDL) particles are able to enter into the arterial intima layer. 
Aggregation or oxidative modifications occur to the LDL due to the vascular wall or 
the immune cells release oxidants into the environment. The LDL receptor mediates 
the endocytosis of cholesterol into hepatic or macrophage cells, removing it from the 
circulatory system. This is a highly regulated process and the LDL receptor is down 
regulated once cholesterol levels get too high, preventing further absorption of LDL 
(Zhao 2006) The LDL receptor recognizes specific amino acid residues on the LDL’s 
apolipoprotein B100 (ApoB100) protein such as lysine, arginine and histidine. 
Oxidative degradation of the ApoB100 causes extensive fragmentation to the protein, 
forming smaller peptides and derivatization of positive lysine residues on the LDL 
molecule, preventing the LDL receptor from recognizing the particle (Esterbauer 
1990, Obama 2007, Levitan 2010). When modifications have occurred to the LDL 
particle, it permits a rapid, unregulated uptake of modified LDL by the macrophages 
scavenger receptors, located on the membrane of the cell. This leads to excessive 
cholesterol accumulation and the differentiation into a lipid-loaded foam cell 
(Steinbrecher 1991, Bobryshev 2006, Jayaraman 2007) which is an early sign of 
atherosclerosis (Ross 1977, Sun 2000).  
 
The response to retention hypothesis indicates that the initiation of the atherogenic 
properties is caused by LDL diffusing beneath the sub-endothelial layer and binding 
(with high affinity) to proteoglycans chain present on the muscle layer (Williams 
1995). Proteoglycans contain long carbohydrate side chains of glycosaminoglycans 
(GAGs), which are covalently attached to a core protein via a glycosidic linkage. 
GAGs have repeating disaccharide units, with negatively charged sulfate or 
carbohydrate groups. Majority of the GAGs are produced by fibroblasts as a part of 
the extracellular matrix (Borén 1998, Evanko 1998, Williams 1998, Alvarez 2006). 
Once LDL moves through the sub-endothelial layer, the positively charged lysine 
residues present on the ApoB100 protein have a high affinity for the negatively 
charged sulfate proteoglycans, causing the LDL to stick to the GAG matrix (Evanko 
1998, Libby 2009). LDL itself is non-toxic to the macrophages until it is caught by 
proteoglycan chains and undergoes oxidation by oxidants produced by vascular cells 
or macrophages. Scavenger receptors, present on the macrophage, uncontrollably 




Aspects from the previous hypothesizes are plausible, however, the oxidative 
modification hypothesis is the commonly accepted theory to explain the events 
occurring in the initial stages of plaque development. The oxidative modification 
theory proceeds via the LDL particles enter into the arterial intima layer where the 
trapped LDL is oxidatively modified by cellular oxidants produced by endothelial or 
smooth muscle cells (Figure 1.1). The endothelial cells produce proinflammatory 
cytokines, adhesion molecules, chemotactic proteins to promote recruitment and 
migration of monocytes to the inflammation area within the intima space. Activated 
monocytes roll, via cell adhesion proteins, along the surface of lumen endothelial 
layer in response to the endothelial cells releasing the proinflammatory signal. The 
monocytes move through the layer and undergo differentiation into macrophages in 
response to the inflammatory cytokines (Figure 1.1). The macrophages produce 
oxidants such as superoxide, hydrogen peroxide and hypochlorite via the NADPH 
oxidase (NOX) complex and myeloperoxidase (MPO) respectively, in attempt to 
oxidize the pathogenic threat. Further lipid and protein oxidation occurs to the 
minimally oxidized LDL, forming oxidized LDL (oxLDL) (Figure 1.1) (Steinbrecher 
1991, Stocker 2004, Bobryshev 2006, Libby 2009). Macrophages are immune cells 
that specialize in removing cellular debris or modified proteins from the body via 
phagocytosis. This is initiated by various scavenger receptors that are expressed on 
the cell’s surface and these receptors are unregulated. 
There is an abundant amount of experimental evidence that supports scavenger 
receptor CD36 in the pathology of atherosclerosis. Research performed by Rahaman 
(2006) demonstrated CD36-null mice showed a significant 70 – 80% inhibition of 
foam cell formation (Rahaman 2006). Additionally, Nozaki (1995) showed a 40% 
reduction of oxLDL uptake in CD36-null human macrophages (Nozaki 1995). 
Suggestions have been made that CD36 binds to the positively charged lysine 
residues that are present on the apoB100 and the oxidized phospholipids on the 
oxLDL particle (Boullier 2001). Scavenger receptors have uncontrolled uptake of 
modified lipoproteins, causing an accumulation of oxLDL within the macrophage 
(Silverstein 2009). A combination of increased oxLDL uptake and the reduced 
oxLDL efflux causes the macrophage to differentiate into a lipid-loaded foam cell 
(Figure 1.1). The accumulation of lipids induces ER stress (Section 1.3.2) and 












Figure 1.1 Early atherosclerotic plaque development 
Native LDL can enter into the intima space and undergo oxidation by cellular oxidants by the 
endothelial, macrophage or smooth muscle cells. The presence of oxLDL recruits macrophage 
differentiated monocytes to the site of inflammation. OxLDL is taken up by the macrophage via the 
scavenger receptor CD36, forming lipid-loaded foam cells. Death of the foam cells results in the 
intracellular content to be released back into the environment, further propagating the inflammation in 
the intima space. 
 
OxLDL induces extensive damage to cells and causes the cells to undergo apoptosis 
or necrosis. The cell’s intracellular content (cellular debris, oxidants, chemotactins 
and cytokines) is released into the environment, contributing to the further 
inflammation and progression of the necrotic core (Figure 1.2). (Madamanchi 2005, 
Gieseg 2009, Libby 2009). Inflammatory cells play a crucial role in the 
destabilization in the plaque’s fibrous cap, resulting in the plaque rupture. 
Inflammatory cytokines (interleukin-1 (IL-1), tumour necrosis factor (TNF), CD140 
and CD-40) can stimulate an up-regulation of matrix metalloproteinases (MMP) in 
macrophages and vascular smooth muscle cells (Mach 1997, Libby 1998). These 
enzymes is responsible for remodelling the extracellular matrix and degrading the 
fibrous cap, making the plaque more prone to rupturing (Galis 1994, Geng 1995). 
Dysfunction of the expression of MMP enzymes is believed to be responsible for the 
rupture of the atherosclerotic plaques (Kim 2004). Once the plaque ruptures, it will 
form an acute thrombosis upstream, flow down and get lodged in smaller capillaries. 
This restricts or completely blocks the blood supply resulting in nutrient deprivation 
and tissue death. The progression of this will often manifest itself as a heart attack or 




Figure 1.2 The progression of atherosclerosis on the artery wall 
The different stages of atherosclerotic plaque development, depicting deposition of lipids (2), the 
formation of the fatty streak (3), formation of the necrotic core and fibrous cap (4) and rupturing of the 
plaque, forming a thrombus. 
 
OxLDL has been shown to induce cytotoxic effects in a variety of cell types including 
macrophages (Gieseg 2010 B), smooth muscle cells (Hsieh 2001), endothelial cells 
(Henriksen 1979), U937 (Katouah 2015) and THP-1 cell lines (Baird 2004). The 
mechanism by which oxLDL exerts its toxicity is still under investigation, but it 
appears that oxLDL induces a variety of mechanisms depending on the cell type. 
Research performed by Ermak (2010) compared the LDL hypochlorite oxidation with 
copper-ion oxidation. The results showed that HOCl oxidized LDL (predominately 
forms protein oxidative products and some lipid oxidative products) and copper 
oxidized LDL (combination of both protein and lipid oxidation products) was just as 
toxic as each other to U937 cells. This suggests that the toxicity of oxLDL is 
predominately from advanced protein oxidation rather than lipid oxidation (Ermak 
2010). Previous researchers claimed that oxysterols, especially 7-ketocholesterol (7-
KC), were the main cytotoxic component of oxLDL (Larsson 2006). However, further 
investigation of 7-KC toxicity showed that U937 cells that had been treated with 
modified oxLDL, enriched with 7-KC, did not increase the toxicity of oxLDL, 
suggesting that 7-KC is not the toxic component (Rutherford 2012). This suggests that 
protein oxidation of the ApoB100 is inducing the cytotoxic effect. 
Other effects observed in U937 and HMDM cells have seen an increase of 
intracellular oxidative stress with a subsequent decrease in cell viability with 
prolonged exposure to oxLDL (Gieseg 2010 B, Chen 2012, Katouah 2015). The 




involved in metabolic processes, such as a reduced activity of GAPDH, aconitase and 
lactate dehydrogenase. (Gieseg 2010 B, Chen 2012, Katouah 2015). Significant 
oxidative damage to the cell with lack of ATP results in necrosis which is a key 
characteristic of oxLDL induced damage (Golstein 2007). This indicates that oxLDL-
induced oxidative stress is the most likely the main initiator of the death cascade. 
1.3 Types of cell death 
When different cell lines are exposed to oxLDL, it can induce different biochemical 
pathways, resulting in the various cell death mechanisms explained below. 
1.3.1 Apoptosis and necrosis 
Apoptosis, also known as programmed cell death is a highly regulated cell death 
mechanism and occurs during development, aging and as a homeostatic mechanism to 
maintain cell populations in tissue. Apoptosis also occurs as a defence mechanism 
such as in immune reactions or when disease or chemical agents damage cells. 
Apoptosis involves a series of intracellular signalling cascades for controlled 
shutdown of the cell. These include maintaining ion homeostasis and intact organelles 
to sustain the ATP production throughout the cell death, as apoptosis cannot occur 
without ATP. Features of apoptosis involve morphological changes such as cell 
shrinkage, plasma membrane blebbing, chromatin condensation, DNA fragmentation 
and apoptotic body formation. Typical biochemical changes comprise of cytochrome 
c release from mitochondria resulting in the activation of caspases and labelling of the 
cell for clearance by phagocytes through exposure of phosphatidylserine on the 
surface of the cell. Biochemical changes during apoptosis involve the release of 
cytochrome c from the mitochondria and a redistribution of phosphatidylserine to the 
outside surface of the plasma membrane, signalling the apoptotic bodies (small 
membrane bound vesicles) for phagocytosis. Phagocytes then engulf the apoptotic 
bodies to entirely remove the cell (Vicca 2003, Vindis  2005,  Elmore 2007). 
 
Necrosis is a unregulated form of cell death mechanism that does not follow the 
apoptotic signal transduction pathway but rather various receptors are activated that 
result in the loss of cell membrane integrity and an uncontrolled release of cellular 
contents into the intracellular space (Golstein 2007). Morphological characteristics 




degradation of organelle structure resulting in disruption of internal organelles, 
nuclear membrane disruption, rupturing of the plasma membrane and release of the 
intracellular content into the extracellular space (Majno 1995, Golstein 2007). 
Necrotic cells release denatured proteins, fragmented DNA, cytokines and cell debris 
into the environment, inducing an inflammatory response (Tabas 1997). Secondary 
necrosis can occur when the apoptotic bodies membrane rupture, resulting in the 
cellular content to pour out into the extracellular space.  
 
1.3.2 Endoplasmic reticulum (ER) stress  
The endoplasmic reticulum (ER) is involved in intracellular signalling by acting as a 
major store of intracellular calcium, initiating the signalling transduction. 
Additionally, it is involved in protein folding and post translational modifications 
(Koch 1990). If there is significant disruption to the ER, the stress response pathway 
called the unfolded protein response (UPR) can activate. Three ER chaperone 
proteins: PKR-like endoplasmic reticulum kinase (PERK), inositol requiring enzyme 
1 (IRE1) and activating transcription factor 6 (ATF6) function as primary sensors of 
ER stress and can sense the accumulation of unfolded proteins within the lumen. 
Chronic accumulation of unfolded proteins results in an up regulation of C/EBP 
homologous protein (CHOP) and after a prolonged elevation can cause a release of 
intracellular calcium which starts the apoptotic signalling transduction, activating the 
caspase pathway, condemning the cell to an apoptotic cell death mechanism (Tabas 
2010). ER stressors that are present within advanced plaque lesion include: oxidative 
stress, oxysterols, high levels of intracellular cholesterol and saturated fatty acids. 
These stressors can lead to chronic activation of the UPR pathway and lead to calcium 
release and the activation of apoptosis (Tabas 2010, Oh 2012). Cholesterol is 
transported out of the cell, onto High-Density Lipoprotein (HDL) ApoA1 proteins via 
ATP binding cassette A1 (ABCA1) and ABCG1 transporters (Gieseg 2009). 7-KC is 
an abundant substituent in oxLDL and has been shown to impair the ABCA1 
transporter, preventing the transport of free cholesterol out of the cell.  This leads to 
membrane vesicles, filled with cholesterol esters, to accumulate in the cytoplasm 
(Brown 1999, Gieseg 2009). A combination of uncontrolled oxLDL uptake and the 
impairment of cholesterol efflux, cause the formation of lipid-loaded foam cells 




sensitive to large quantities of free cholesterol. The movement of free cholesterol into 
the ER membrane triggers the UPR by stiffening of the ER membrane, causing the 
phospholipids to become more organized and tighter packing. This process causes 
dysfunction of the ER integral membrane proteins and induces UPR. The UPR 
activates signalling pathways that promote apoptosis cell death through the activation 
of specific caspases (Section 1.3.1) or CHOP (Tsukano 2010, Oh 2012). Cells that die 
within the atherosclerotic plaque release the cholesterol back into the environment, 




1.4 Oxidative stress  
1.4.1 Oxidants 
The generation of oxidants is a normal physiological process as a result of exercise, 
metabolism and immune system defence against pathogens. Radicals are highly 
reactive molecules that are formed as a result of incomplete electron transfer to 
another molecule, to form an oxidative species. These are capable of oxidizing 
biochemical molecules, causing further damage (Banerjee 2003). Species such as 
superoxide radical (O2
-
), hydrogen peroxide (H2O2), hydroxyl radical (
•
OH) and 
hypochlorite (HOCl) are all generated from biochemical processes (Figure 1.4) and if 
not utilized in the correct function then they can be extremely damaging to other 
biomolecules (Sies 1997, Hemnani 1998, Al Ghouleh 2011). Oxidative stress is an 
imbalance of oxidants generated in the body and the inability of the biological system 
to detoxify the reactive species resulting in damage to all components of the cell such 




















Figure 1.3 Oxidative mechanism of macrophages against pathogens 
Macrophages generate superoxide anions via NADPH oxidase that can be rapidly dismutated to 
hydrogen peroxide by superoxide dismutase (SOD). Hydrogen peroxide can either: breakdown into 
hydroxyl radicals via the fenton reaction, form hypochlorite via myeloperoxidase or breakdown into 
water via catalase. 
 
 
In extreme cases of oxidative stress, cell death occurs through inactivation of essential 
enzymes by oxidation of the essential amino acid side chains in the active site or 
damage to the plasma membrane (Liu 2006). Cell damage will result in failure of 
cellular processes and will undergo either apoptosis or necrosis explained in Section 
1.3. Oxidative damage can occur to cell membrane receptors through oxidation at the 
phosphorylation sites and preventing ligands from recognizing the binding sites. 
Oxidative damage to ion channels in the plasma membrane prevents ions from 
properly flow in and out of the cell. This creates an imbalance of the distribution of 
water due to an influx of calcium ions will move into the cell, causing swelling of the 
cell and triggering necrosis (Matsuura 2006). Oxidants are naturally removed by 
cellular antioxidant systems, which include vitamins (C, E), antioxidant enzymes 
(glutathione) or cellular generated antioxidants such as 7,8-dihydroneopterin (Section 
1.5). Antioxidants function by reacting with the oxidant faster than the oxidant can 
react with biomolecules. Antioxidants have a π conjugated ring motif that enables 
delocalization of unpaired electrons, stabilizing the molecule and preventing it from 
further reacting with other biomolecules. (Sies 1997, Valko 2007) Inflammation of 
the tissue is a complex biological response in which the immune system releases 
numerous different oxidants into the environment in an attempt to alleviate the 
harmful stimulus such as pathogen or irritant. Inflammatory diseases are a result of 
the immune system generating a wide array of oxidants into the site of inflammation 
creating an oxidative stress environment that causes excessive tissue damage which in 





1.4.2 Oxidative stress and atherosclerosis 
Oxidants can cause oxidative damage to the lipid and protein components of the LDL 
particle, transforming the particle into the high uptake form (oxLDL) and inducing the 
differentiation of macrophages into foam cells (Fu 1998). Additionally, oxidative 
stress can cause cell death, contributing to the necrotic core and driving the transition 
of early plaque development into an advanced plaque (Tabas 1997). OxLDL has been 
shown by researchers to be cytotoxic to a variety of different cell lines, initiating an 
oxidative stress response in HMDM and U937 cells (Gieseg 2010 B, Katouah 2015). 
It has been shown by Katouah (2015) that not only are the macrophages producing 
oxidants into the environment, causing tissue damage and LDL oxidation, but the 
oxLDL is causing an overproduction of intracellular oxidative stress after 3 hours. 
Intracellular oxidative stress has been shown to deplete intracellular glutathione 
levels, inactivate essential glycolytic enzymes such as GAPDH, aconitase, causing a 
loss of ATP and the cell is unable to control the cell death, resulting in necrosis 
(Gieseg 2010 B, Katouah 2015). Several enzymatic systems have been viewed as 
potential sources of intracellular oxidant production: these include xanthine oxidase, 
lipooxygenases, cyclooxygenases, cytochrome P450, nitric oxide synthase, uncoupled 
enzymes of the mitochondria electron transport chain (Section 1.6) and NADPH 
oxidase (Section 1.7) (Ballinger 2005, Madamanchi 2007, Al Ghouleh 2011). As 
NOX’s major role is to produce superoxide anions to eliminate pathogens in 
inflammatory sites, it is considered to be the predominant source of intracellular 













1.5 7,8-Dihydroneopterin (7,8-NP)  
1.5.1 Biosynthesis of 7,8-NP  
Macrophages, monocytes, dendritic cells and fibroblasts are the only known cell types 
to produce substantial amounts of 7,8-NP in physiological conditions. The biopterin 
pathway begins with a two-step synthesis with the cleavage of guanosine-5’phosphate 
(GTP) by GTP-cyclohydrolase-I, yielding 7,8-dihydroneopterin (7,8-NP) 
triphosphate. The biosynthetic pathway is shown in Figure 1.4, representing the two 
possible branch points to either 7,8-dihydroneopterin or tetrahydrobiopterin from the 
precursor 7,8-NP triphosphate (Werner-Felmayer 1990, Thony 2000, Walter 2001, 
Fuchs 2009). 
Figure 1.4 The pterin biosynthetic pathway 
The 7,8-NP biosynthesis pathway involves the conversion of GTP to 7,8-dihydroneopterin triphosphate 
(7,8-DNT) via GTP cyclohydrolase-I (GCH-I). The accumulation of 7,8-DNT in myelocytic cells 
drives the flux to dephosphorylation of 7,8-DNT to 7,8-dihydroneopterin (7,8-NP) as they have 
insufficient 6-pyruvonyltetrahydropterin synthase (PTPS). Alternatively, non-myelolytic cells have 
functional PTPS, driving the flux to tetrahydrobiopterin (BH4). Diagram was taken from Parker (2015) 
and permission was received.  
 
Tetrahydrobiopterin (BH4) is an essential cofactor in multiple biological processes, 
including inducible nitric oxide synthase (NOS) (Channon 2004) and plays an 
essential role in various aromatic amino acid hydroxylations (Walter 2001, Leitner 
2003, Fuchs 2009). 7,8-Dihydroneopterin (7,8-NP) triphosphate is generated by two 
subsequent enzymes, 6-pyruvonyltetrahydropterin synthase (PTPS) and sepiapterin 
reductase (SR), producing BH4 (Figure 1.4). Human macrophages and related cell 




fact that PTPS activity is considerably low in these cell types owing to a specific exon 
3 skipping in PTPS pre-mRNA causing a premature stop codon (Leitner 2003). Non-
macrophage cell types possess fully functional PTPS, producing large amounts of 
BH4 (Leitner 2003). 7,8-NP is product that is produced from the precursor 7,8-NP 
triphosphate and has been shown to provide antioxidant properties in in vitro research 
(Gieseg 1995, Gieseg 2001 A). In human macrophages and related cell types, there is 
higher concentrations of 7,8-NP triphosphate available, driving the flux towards 7,8-
NP production. This is achieved by non-specific phosphatases cleave the triphosphate 
off 7,8-NP triphosphate to produce 7,8-dihydroneopterin (7,8-NP) (Figure 1.4). 7,8-
NP is readily oxidized by oxidants to produce a series of oxidative products including: 
neopterin, xanthopterin, dihydroxantopterin as seen in Figure 1.5.  
 
 
Figure 1.5 Oxidative mechanisms of 7,8-dihydroneopterin 
Breakdown products are depicted as 7,8-NP reacting with an oxidant into neopterin, 7,8-
dihydroxanthopterin and xanthopterin that can oxidize further into an unknown product. Diagram was 
taken from Parker (2015) and permission was received. 
 
In in vitro studies, 7,8-NP is oxidized to a highly fluorescent product called neopterin 
and is utilized as a clinical marker for immune cell activation. Patients suffering from 
cardiovascular disease have been shown to have significantly elevated levels of 
neopterin in their plasma (Schumacher 1992) and in their atherosclerotic plaques 
(Schumacher 1997, Gieseg 2008). During inflammation, macrophages are stimulated 
by a pro-inflammatory cytokine, interferon gamma (-INF) derived from activated T-
cells. This stimulant up regulates GCH-I and induces the breakdown of GTP to 





1.5.2 Antioxidant properties of 7,8-dihydroneopterin on cell viability 
As explained above, primate macrophages lack the enzyme required to produce 
tetrahydrobiopterin causing the flux of intracellular 7,8-dihydroneopterin to increase 
and leak into the extracellular environment. The exact reason for this is currently 
unknown although -INF (a pro-inflammatory cytokine) up regulates the production 
of 7,8-NP which suggests that 7,8-NP role is to protect the human macrophage from 
oxidative stress environments (Andert 1992, Gieseg 1995, Gieseg 2001 A). 7,8-NP is 
a potent antioxidant which has been shown in numerous studies to inhibit oxidation of 
low-density lipoprotein, linoleic acid, lysis of red blood cells and oxidation of 
tyrosine residues (Gieseg 1995, Gieseg 2001 A). Others studies found 7,8-NP to 
protect U937 cells from AAPH derived peroxyl radicals (Baird 2005) and protect 
against the secondary protein hydroperoxide formation from copper and AAPH 
mediated lipid oxidation (Gieseg 2003). Research carried out by our laboratory have 
shown oxLDL to be extremely toxic to U937 cells after 3 hours, demonstrating a 
concentration dependent increase of intracellular oxidative stress followed by a loss of 
GSH and enzymatic activity of GAPDH and aconitase. Addition of 7,8-NP inhibited 
the intracellular oxidative stress generated within the cell reducing the GSH loss and 
enzyme inactivation (Baird 2005, Katouah 2015). Incubation of human monocyte 
derived macrophages (HMDM) with oxLDL and increasing concentrations of 7,8-NP 
showed a significant concentration dependent increase in cell viability of up to 80% at 
200µM 7,8-NP (Gieseg 2010 B). This suggests that 7,8-NP is scavenging the 
intracellular oxidants produced by oxLDL and protecting the biomolecules within the 
cell and restoring the cell viability. 
1.6 Mitochondria 
The mitochondrion is a multi-layer structure consisting of the outer mitochondrial 
membrane (OMM), intermembrane space, inner mitochondrial membrane (IMM) and 
the matrix (Figure 1.6). Its main function is to generate ATP through oxidative 
phosphorylation within the respiratory chain where the electron transport chain (ETC) 
is coupled to the production of ATP from ADP (Madamanchi 2005, Yu 2014). The 
ETC complex consists of 5 smaller complexes: Complex I (NADH-ubiquinone 
dehydrogenase), Complex II (succinate cytochrome c reductase), Complex III 




Complex V (ATP synthase) (Figure 1.6).  NADPH and FADH2 are both produced 
from the Krebs cycle (previous metabolic process) and NADPH transfers electrons 
onto complex I and FADH2 transfers electrons to complex II. Electrons are then 
passed to ubiquinol via an electron carrier, coenzyme Q10, which passes the electrons 
on to complex III. Cytochrome c accepts the electrons and passes them on to complex 
IV, which transfers the electrons on to molecular oxygen, forming water. Whilst 
electrons are being passed along the complexes, complex I, III and IV are establishing 
an electrochemical gradient by passing hydrogen ions from the matrix, through the 
inner membrane, into the inner membrane space. Complex V (ATP synthase) utilizes 
this hydrogen electrochemical gradient to cross the inner membrane space to get back 
to the matrix with the synthesis of ATP from ADP and an inorganic phosphate. The 
hydrogen re-entry moves through complex V, generating the movement of the 
complex to synthesize ATP (Figure 1.6) (Madamanchi 2007). As a result, energy 
production produces oxidants as a byproduct from the movement of electrons through 
the complexes onto oxygen molecules (Liu 2002). Complex I and III have been 
considered to be the primary sites for electron leakage to generate oxidants, 
contributing up to 4% of molecular oxygen consumed by the mitochondria (Figure 
1.6) (Lenaz 2002, Madamanchi 2007).  
Figure 1.6 The mitochondrial electron transport chain 
An illustration of the mitochondria electron transport chain, displaying the order of complexes, leakage 




Significant literature has suggested that the mitochondria has an intimate relationship 
in development of atherosclerosis (Ballinger 2005, Madamanchi 2007, Wang 2014). 
The mitochondria is an essential organelle as it is involved in the energy production 
and death of the cell. As a result it has been linked as a potential source and primary 
target of oxidative stress (Murphy 2009). If significant damage has occurred to the 
mitochondria and is unable to produce ATP, the reverse electron transport 
phenomenon can occur. The electrons derived from FADH2 via complex II can 
reversely flow back to complex I and has the potential to generate oxygen radicals 
(Liu 2002, Han 2003). Superoxide that is generated in the mitochondrial matrix is 
converted into hydrogen peroxide by superoxide dismutase (SOD), which then can be 
converted into water by glutathione peroxidase (Figure 1.6). Transition metals are 
capable of reducing hydrogen peroxide into hydroxyl radicals via the Fenton reaction 
(Mao 1993, Turrens 2003, Madamanchi 2007). Superoxide has the potential to react 
with nitric oxide (NO) to produce peroxynitrite, which can inactivate enzymes, 
oxidize DNA and cause mitochondria dysfunction (Ballinger 2000, Turrens 2003). 
All of oxidants produced are able to react with biomolecules present within the 
mitochondria, contributing to the oxidative damage and further dysfunction of the 
enzymes (Liu 2002, Turrens 2003). There is a lot of speculation of the role the 
mitochondria has in atherosclerosis. Studies have indicated that the cellular oxidative 
stress generated from NOX could act as a possible feedback, causing an increased 
production of radicals from the dysfunction mitochondria (Brandes 2005). In addition, 
a loss of ATP production through oxidative damage would cause an increase of 
oxidant production through reverse electron transport from complex I, enhancing the 
cell-mediated oxidant production (Liu 2002, Hort 2014). 
 
1.7 NADPH oxidases (NOX) 
1.7.1 NOX structure and Activation 
NADPH oxidase (NOX) is a membrane-bound complex that is present in phagocytic 
cells such as neutrophils, macrophages and dendrites. Its primary function is to 
catalyze the production of superoxide anion radical from the reduction of NADPH 
and molecular oxygen in the presence of pathogens. Cytochrome b558 is a membrane 
bound heterodimer consisting of two catalytic subunits, gp91phox and p22phox (Figure 




components (consist of p47phox, p67phox and Rac-GTPase) to the membrane-bound 
component (Cytochrome b558). This allows the transfer of electrons from NADPH to 
molecular oxygen resulting in the production superoxide anions (Figure 1.7) (Vignais 










Figure 1.7 The structural components of NOX-2 at resting and activated states 
Assembly of NADPH oxidase through the translocation of P47phox, P40phox, P67phox and a small 
GTP protein (Rac) to the membrane bound complex, gp91phox and p22phox. This activates the 
complex that causes the transfer of electrons from NADPH to molecular oxygen to produce superoxide 
anions.  
 
Six homologs of neutrophil NOX-2 have been found in non-phagocytic mammalian 
cells, all displaying conserved regions of NADPH and FAD binding sites. NOX-1, 
NOX-3 and NOX-4, all have similar structures to NOX-2; while the others have N-
terminal extensions, containing two calcium binding EF hands for NOX-5 and have 
additional peroxidase domains for DUOX 1 & 2 (Bánfi 2001, Bánfi 2003, Lardy 
2005). NOX-1 is found mainly in colon epithelium cells and has been proposed to 
regulate cell growth and participate in cell defence, NOX-4 in kidney cortex and 
mediates oxygen sensing, or DUOX-1, 2 which is involved in thyroid hormone 
synthesis (Bánfi 2001, Bánfi 2003, Brandes 2010). NOX-5 is found in lymphoid 
organs and testis and similar to NOX-2, generates large amounts of superoxide in 
response to an increase in cytosolic calcium. NOX-1 and 4 generates very little 
superoxide unless it is stimulated by P67phox and P47phox (Bánfi 2001, Takeya 2003, 
Bedard 2007). However, NOX-2 is the homolog of interest as it is the only known 
NOX to be in activated phagocytic cells. Once stimulated, the complex generates 
large amounts of superoxide anions in response to foreign pathogens (Bellavite 1988, 




1.7.2 NOX and its role in atherosclerosis 
NOX has been described throughout the literature as the major superoxide generator 
in phagocytic cells in response to a foreign stimulus. In the past 10 years, the 
literature is escalating the importance of NOX in inflammatory diseases such as 
atherosclerosis. OxLDL, the major cytotoxic agent in the progression of 
atherosclerosis, has been suggested to activate NOX-2 and generate an 
overproduction of oxidative stress within HMDM and U937 cells (Gieseg 2010 B, 
Katouah 2015). It was demonstrated in human atherosclerotic plaque, there was an 
increase of NOX-2 expression, parallel with the atherosclerotic plaque development 
(Goncharov 2015). Additionally, the NOX-4 expression remained constant through 
plaque development (Sorescu 2002).  However, it was shown in human aortic smooth 
muscle cells (HASMC) that there was increased NOX-4 protein expression with 7-KC 
exposure. As NOX-4 predominately generates hydrogen peroxide rather than 
superoxide, it was shown that 7-KC induced up-regulation of NOX-4 expression, 
accompanied with higher intracellular hydrogen peroxide levels (He 2013). It is 
currently unclear how oxLDL interacts with the NOX complex. Studies have 
suggested that oxLDL can activate NOX via the CD36 scavenger receptor in smooth 
muscle cells (SMC) (Sukhanov 2006, Pongnimitprasert 2009). Excessive generation 
of superoxide in smooth muscle cells caused a significant loss of GAPDH activity, 
causing the cell to undergo necrosis as it was unable to generate ATP (Morgan 2002). 
The loss of GAPH activity was prevented by the use of NOX inhibitors (Sukhanov 
2006) and 7,8-NP (Katouah 2015). Oxidant production and GAPDH loss has been 
shown to be prevented by anti-CD36 antibodies in SMCs. This suggests that NOX 










1.7.3 NOX inhibitors 
A large number of studies are attempting to elucidate the role NOX has in the oxLDL-
induced oxidative stress mechanism by the use of NOX inhibitors. Gp91ds-tat and 









Figure 1.8 Inhibition of NOX through peptide and non-peptide inhibitors.  
Apocynin and gp91ds-tat inhibitors prevent the translocation of P47phox subunit to the gp91phox 










Figure 1.9 Chemical structure of apocynin 
   
Apocynin (4,hydroxyl-3methoxy-acetophenone) (Figure 1.9) is originally isolated 
from Picroria kurroa plant and has been greatly studied for its  role as a potent 
inhibitor of superoxide generation in activated neutrophils and vascular smooth 
muscle cells (VSMC) (Stolk 1994, Van den Worm 2001, Williams 2007). The exact 
mechanism of how apocynin inhibits NOX is currently unclear but it is thought to 
prevent the assembly of NOX by interfering with the translocation of P47phox to the 




Apocynin is a pro-drug that needs to be activated or oxidized before it is a potent 
inhibitor of NOX. Apocynin is oxidized in the presence of myeloperoxidase (MPO) 
and hydrogen peroxide, which is abundant in phagocytic cells (neutrophils). The 
active metabolite forms dimers and trimer derivatives resulting in diapocynin 
formation. Diapocynin is then thought to react with thiol groups that are essential in 
the assembly of NOX, preventing the translocation of P47phox and gp91phox (Stolk 
1994, Touyz 2008). These properties indicate that apocynin is only activated at sites 
of inflammation (Stolk 1994). Convincing data from in vitro studies show that 
activated apocynin produced from phagocytic cells can effectively reduce superoxide 
production in endothelial cells, vascular smooth muscle cells, and adventitial 
fibroblasts through inhibition of NOX complex (Stolk 1994, Van den Worm 2001, 
Touyz 2008, Kanegae 2010). All of the previous in vitro studies demonstrated that 
apocynin effectively inhibited NOX complex, thus inhibiting superoxide generation, 
although research performed by Heumueller et al (2008) highlighted that phagocytic 
cells and non-phagocytic cells have different apocynin mechanisms. Non-phagocytic 
cells (HEK293 cells) do not possess MPO, therefore activated apocynin cannot be 
formed and cannot inhibit NOX activation or superoxide generation. However, they 
demonstrated that apocynin can act as an antioxidant by scavenging radicals formed, 
especially hydrogen peroxide (Lapperre 1999, Heumüller 2008, Touyz 2008) 
Apocynin has also been shown to act as an antioxidant by enhancing intracellular 
glutathione synthesis through increasing the activity of gamma-glutamylcysteine 
synthase in A549 cells by activating the transcription factor  AP-1, however, an over 
production of GSH can cause the cell to go into reductive stress (Lapperre 1999). 
Similar results were observed in U937 cells, as apocynin reduced the intracellular 
oxidative stress induced from oxLDL but caused a subsequent increase of intracellular 
glutathione and providing little cell viability protection. This indicated that the U937 






Figure 1.10 Structure of gp91ds-tat NOX inhibitor 
 
Gp91ds-tat (gp91phox docking sequence – Trans-Activator of Transcription) has an 
inhibitory effect on NADPH Oxidase by preventing the assembly of the gp91phox with 
P47phox, therefore stopping the transfer of electrons from NADPH to oxygen to 
produce superoxide (Figure 1.8). The peptide sequence specifically binds to P47phox, 
mimicking the region of gp91phox and preventing the assembly and activation of NOX 
(Rey 2001, Williams 2007, El-Benna 2010). Rey et al. (2001) identified the gp91phox 
sequence from a mouse homolog, calling it gp91phox ds and later added the a 
translocating peptide domain (tat) to the end, forming a 20 amino acid long sequence, 
gp91ds-tat (Figure 1.10) (Rey 2001, Williams 2007). When using peptide inhibitors, 
the main obstacle is getting the peptide across the plasma membrane lipid bilayer in 
living intact cells to inhibit NOX. This is accomplished by using cell-penetrating 
peptide (CPP) or protein transduction domains (PTD) attached to the inhibiting 
protein. TAT (Trans-Activator of Transcription) is a CPP domain and is derived from 
the human immunodeficiency virus (HIV1). This peptide’s function is to deliver 
biomolecules that is naturally impermeable to the cell, across the plasma membrane 
into the extracellular space to achieve a desired effect (Debaisieux 2012). The 
gp91ds-tat peptide inhibitor has a tat CPP domain attached to the end of the peptide to 
allow bioavailability into the cell to inhibit NOX from generating super oxide anions 
(Figure 1.10) (Rey 2001, El-Benna 2010). Studies have shown gp91ds-tat to be a 
highly specific competitive inhibitor of NOX so far. Research performed in vitro 




decreasing oxidase activity and superoxide generation in neutrophils and mouse aorta 
(Rey 2001). It was shown that in cell free assays, the peptide inhibitor significantly 
decreased the oxidases activity of up to 80% (Rey 2001). Although gp91ds-tat is 
effective in reducing superoxide production in animals and cell systems, Rey (2001) 
states that when administered orally, it has a relatively low bioavailability, limiting 
the clinical application (Rey 2001). Gp91ds-tat is effective in the NOX homologs that 
contain the gp91phox and P47phox subunits (NOX1 and NOX2) and unlikely to be 
effective in homologs that are significantly different (NOX4 and NOX5) (Williams 
2007). 
1.8 Myeloperoxidase (MPO) 
1.8.1 Biology of MPO 
Activated neutrophils are a highly effective defence against foreign microorganisms, 
as they provide the necessary cytotoxic agents to kill the microbes that invade the 
human body (Hampton 1998, Prokopowicz 2012).  Myeloperoxidase (MPO) is a 
peroxidase enzyme, which is secreted by activated neutrophils and is released in 
conjunction with hydrogen peroxide (generated indirectly from NOX complex), for 
antimicrobial activity. Hydrogen peroxide is generated from the reaction of 
superoxide anions and hydrogen via superoxide dismutase (Reaction 1).   
 Reaction 1 2 O2
•-
 + H2 → O2 + H2O2  




 → HOCl + H2O  
As hydrogen peroxide is only toxic at high concentrations and NOX generated 
superoxide does not kill the bacteria directly, MPO generates a potent secondary 
oxidant (hypochlorite) from hydrogen peroxide and a chloride anion during the 
respiratory burst (Reaction 2) (Hampton 1998, Brennan 2001, Exner 2004, 
Prokopowicz 2012). Majority of the oxygen consumed from the immune respiratory 
burst can be accounted in the hydrogen peroxide generated by the dismutation of 
superoxide radical (Hampton 1998, Brennan 2001, Davies 2011). The reaction 
mechanisms of MPO can be seen in Figure 1.11. Ferric myeloperoxidase (MP
3+
) 
reacts with hydrogen peroxide to form the intermediate compound I. This enables 
compound I to oxidize either a chloride ions to produce hypochlorite and restoring the 
enzyme back to its MP
3+
 state.  Compound I can also oxidize organic substances (RH) 




When superoxide anions are present, compound II can be recycled back to the native 
enzyme state (MP
3+
). Poor substrates or if superoxide is not present then the MPO 
enzyme is trapped as the compound II intermediate, inhibiting the hypochlorite 
production. Superoxide can convert the native state into compound III which further 
reacts with superoxide to compound I which may oxidize chloride ions or react with 
organic substrates (Hampton 1998, Malle 2007, Davies 2011).  
 
Figure 1.11 Reaction mechanisms of myeloperoxidase 
The reaction mechanism shows the enzymatic intermediates of the enzyme myeloperoxidase, utilizing 
hydrogen peroxide and chloride ions to produce hypochlorite. Illustration adapted from Hampton 
(1998). 
1.8.2 Role of MPO in Atherosclerosis 
Hypochlorite (HOCl), is a strong oxidizing agent that primarily attacks the ApoB100 
on the LDL particle, forming protein chloramines and leading to the atherogenic 
effects seen in cardiovascular disease (Brennan 2001, Yang 2012 A). High 
concentrations of HOCl kills human monocyte derived macrophages by oxidizing and 
causing a necrotic cell death (Yang 2012 A). It has been previously observed that 
hypochlorite can oxidize 7,8-NP with high efficiency, generating large quantities of 
neopterin (Widner 2000, Gieseg 2001 B, Parker 2015). Additionally, both MPO and 
its oxidative products have been found within atherosclerotic lesions (Hazen 1997). 
These findings has led to the theory that hypochlorite forms the basis of neopterin 
formation during inflammation (Widner 2000). This implies that hypochlorite 
generated during inflammation may be responsible for the neopterin observed in 
plasma and urine during immune system activation (Fuchs 1989, Schumacher 1997, 














Figure 1.12 Chemical structure of 4-aminobenzoic acid hydrazide (ABAH) 
 
ABAH (4-aminobenzoic hydrazide) (Figure 1.12) is a potent MPO inhibitor which 
functions by irreversible inhibition of MPO. Myeloperoxidase oxidizes ABAH to a 
radical form which in turn reduces the native enzyme into a ferrous intermediate. The 
ferrous MPO can rapidly react with oxygen to form compound III (MP
2+
O2) which 
can lead to turn over to the native enzyme. In the absence of oxygen, the ferrous MPO 
can react with hydrogen peroxide and it’s haem groups were rapidly destroyed, 
leaving the enzyme irreversibly inactivated (Kettle 1997). ABAH has been studied as 
a potential inhibitor for MPO to help elucidate the role MPO has in the inflammatory 
process in cardiovascular disease. It was observed in a study that ABAH irreversibly 
inhibited hypochlorite production by 90% in stimulated neutrophils treated with 
phorbol myristate acetate (PMA) (Kettle 1995). 
1.8.3.2 Thiocyanate 
Humans naturally obtain SCN
- 
through the consumption of plant material and human 
plasma levels vary between 10 – 140 µM (Xu 2009, Chandler 2012). Thiocyanate 
ions  are important in a biological context for multiple reasons: It can limit harmful 
accumulations of hydrogen peroxide by an enzymatic reaction with lactoperoxidase 
(LPO) (Figure 1.13 Reaction 1). The enzyme catalyzes the oxidation of SCN
-
 while 
consuming hydrogen peroxide, forming OSCN
-
 which is tissue innocuous or nontoxic 
to human cells (Figure 1.13 Reaction 2), but is an effective antimicrobial agent 
(Tahboub 2005, Xu 2009, Chandler 2012). Secondly SCN
-
 has been shown to 
effectively compete as a substrate against Cl
-
 ions for myeloperoxidase, reducing the 
production of hypochlorite (Xu 2009). Thiocyanate can also rapidly reduce 
hypochlorite, producing OSCN
-
 and leaving Cl
-




requirement of catalysis (Figure 1.13 Reaction 3). Previous research from Xu (2009) 
showed that LPO catalyzed the oxidation of thiocyanate ions, protecting a human lung 
endothelial cell line by reducing the hydrogen peroxide induced damage. The study 
also showed that MPO has a higher affinity for SCN
-





 and suppressing hypochlorite production (van Dalen 1997, Xu 2009). 
 
Figure 1.13 The enzymatic reaction of MPO and the antioxidant properties of 
SCN- ions 
The illustration shows the antioxidant properties of thiocyanate ions by competing against chloride ions 
to prevent the formation of hypochlorite. Diagram adapted from Xu (2009).   
 
1.9 Objective of research 
Cell death is a major event in the progression of the necrotic core and oxLDL has 
been implicated as the cytotoxic agent (Colles 2001). Previous research has shown 
oxLDL to increase the oxidative stress inside U937 cells, resulting in a depletion of 
intracellular glutathione. The oxidative stress inactivates essential metabolic enzymes 
such as GAPDH and aconitase, causing the death of the cell from metabolism failure 
(Chen 2012). It is currently unknown the source of intracellular oxidative stress, 
however, NADPH oxidase (NOX-2), mitochondria and myeloperoxidase are all 
known sites to produce oxidants. 
 
In this study it is hypothesized that oxLDL can activate the NOX complex and trigger 
an overproduction of intracellular superoxide, resulting in subsequent cell death. It is 
thought that NOX is the primary source of intracellular oxidative stress, to validate 
this hypothesis, in vitro research will determine if the oxLDL-induced oxidant 




Secondly, gp91ds-tat and apocynin will be used in PMA-activated plaque sections to 
determine if the inhibition of NOX will prevent 7,8-NP oxidation. If the inhibition of 
NOX reduces the intracellular oxidant production and prevents 7,8-NP oxidation, then 
it will implicate NOX as the major oxidant producer in both in vivo and in vitro 
research. The second part to this thesis will investigate the mitochondria as a potential 
source of intracellular oxidative stress as a result of oxLDL. Previous research have 
detected increased mitochondrial superoxide generation in response to oxLDL 
exposure (Chen 2012).  
 
This study will determine what time frame is oxLDL inducing mitochondrial 
dysfunction by using a mitochondria specific dye and determine if the mitochondria 
dysfunction can be saved by a potent antioxidant, 7,8-dihydroneopterin. The timing of 
mitochondria dysfunction will be compared to the generation of cytosolic oxidative 
stress to determine if oxLDL is directly damaging the mitochondria or generation of 
intracellular oxidative stress is damaging the mitochondria.  
 
The third part of this thesis will investigate myeloperoxidase as a potential source of 
intracellular oxidative stress as a result of oxLDL exposure. The aim of this section is 
to determine if hypochlorite is causing oxidative extensive damage to cell causing 
subsequent cell death. This will be validated by the use of two myeloperoxidase 
inhibitors (thiocyanate ions and ABAH) to determine if hypochlorite is causing U937 
cell death as a result of oxLDL exposure. 
 
This research will aid in the understanding of the mechanism of the oxLDL induced 
oxidative stress and determine if the inhibition of oxidative stress will restore the 




2. MATERIALS & METHODS 
2.1 Reagents, media and buffers 
2.1.1 Reagents 
All reagents were of analytical grade. All solutions were prepared with deionized 
water purified with a Milli-Q ultrafiltration system (Millipore, Massachusetts, USA). 
This water is referred to as Nano-pure water in this thesis. 
 
7,8-Dihydroneopterin (7,8-NP)    Schircks Laboratory, Switzerland 
7,8-Dihydroxanthopterin (7,8-DXP)   Schircks Laboratory, Switzerland 
Acetic acid (glacial)     Scharlau Chemie S.A., Barcelona, Spain 
Acetonitrile (ACN)     J.T. Baker, NJ, USA 
Ammonium phosphate dibasic (AmPO4)  Sigma-Aldrich Co. LLC, New Zealand 
Apocynin     Sigma Chemical Co., Missouri, USA 
Argon gas      BOC Gases, Auckland, New Zealand 
Bovine serum albumin (BSA)    Sigma-Aldrich Co. LLC, New Zealand 
Chelex®100 resin     Bio-Rad Laboratories, California, USA 
Cholesterol reagent    Roche Diagonostics, USA 
Copper Chloride (CuCl2)   Sigma Chemical Co., Missouri, USA 
Ethylene-diamine-tetra-acetic acid (EDTA)  Sigma-Aldrich Co. LLC, New Zealand 
Dihydroethidium     Invitrogen., Oregon, USA 
Dimethyl suoxide (DMSO)    BDH Lab Supplies Ltd, Poole, England 
Ethanol      BDH Lab Supplies Ltd, Poole, England 
Flow Cytometry chemicals   BD Accuri Cytometers, Ann Arbor, MI, 
USA. 
Hydrochloric acid (HCl)    BDH Lab Supplies, Poole, England 
JC-1      Invitrogen, Oregon, USA 
Methanol      Merck, Darmstadt, Germany 
Nitrogen gas     BOC Gases, Auckland, New Zealand 
Neopterin      Schircks Laboratory, Switzerland 
Phorbol 12-myristate 12-acetate   Sigma Chemical Co., Missouri, USA 
Phosphoric acid     Sigma-Aldrich Co. LLC, New Zealand 
Potassium chloride (KCl)    Merck, Darmstadt, Germany 
Propidium iodide (PI)    Invitrogen., Oregon, USA 




Sodium dihydrogen orthophosphate   Merck, Darmstadt, Germany 
Sodium hydroxide (NaOH)    Merck, Darmstadt, Germany 
Sodium Thiocyanate (NaSCN)   Sigma-Aldrich Co. LLC, New Zealand 
Tetramethylrhodamine, methyl ester (TMRM) Invitrogen., Oregon, USA 
Triton X100     Sigma-Aldrich Co. LLC, New Zealand  
Trypan blue solution (0.4%)    Sigma-Aldrich Co. LLC, New Zealand 
Tween-20      Sigma-Aldrich Co. LLC, New Zealand 
2.1.2    Media 
Penicillin/Streptomycin solution,   Invitrogen, Life Technologies, New Zealand 
1000 U of Penicillin G & 
1000 μg of Streptomycin/mL 
Roswell Park Memorial Institute 1640: 
- RPMI 1640 media, with phenol red   Sigma-Aldrich Co. LLC, New Zealand 
- RPMI 1640 media, without phenol red   Sigma-Aldrich Co. LLC, New Zealand 
2.1.3    General solutions and buffers 
A) Roswell Park Memorial Institute 1640 (RPMI 1640) 
RPMI1640 with and without phenol red powder was supplied by Sigma- Aldrich Co. 
LLC, New Zealand. The media was prepared according to the manufacturer’s 
instructions. Schott bottles were acid washed by adding 50mL of 65% nitric acid and 
rinsed 3 times with distilled water and autoclaved for 15minutes at 121C and 15 psi. 
The media was prepared by dissolving the RPMI1640 powder in nano-pure water, 
followed by the addition of sodium bicarbonate (2g/L). The pH was adjusted to 7.2 – 
7.4 by 37% fuming hydrochloric acid or 10M sodium hydroxide. The media was 
filter-sterilized through a 0.22m membrane MillexR-GP filter/ a 0.20m  Sartolab®-
P20 filter (Sartorius AG, Goettingen, Germany) using a pump (CP-600, Life 
Technologies) into sterilized 500mL bottles. 
B) Phosphate buffered saline (PBS) 
PBS solution contained 150mM sodium chloride (NaCl) and 10mM sodium 
dihydrogen orthophosphate (NaH2PO4) at pH 7.4. The solution was prepared by 
mixing 50 mL of 3M NaCl, 40mL of 250 mM NaH2PO4, pH 7.4 and 910 mL of nano-
pure water. PBS that is required for sterile cell culture experiments was vacuum 




C) Ammonium dihydrogen phosphate (AmPO4) 
A 20mM AmPO4 solution for HPLC was prepared by weighing 2.64g of powder and 
added to 900 ml of nano-pure water while magnetic stirring.  The pH was then 
adjusted to 2.5 using concentrated orthophosphoric acid and made up to 1 litre. The 
solution was then filtered through a 0.45m membrane (Phenomenex) into a 1-litre 
schott bottle under vacuum. 
D) 7,8-Dihydroneopterin solution 
A 2mM 7,8-dihydroneopterin (7,8-NP) (Schircks Laboratories, Switzerland) stock 
solution was prepared in RPMI 1640 media, in a 15mL screw top centrifuge tube 
(Greiner, Greiner Bio-one, Neuburg, Germany). The solution was sonicated for 10 
minutes to dissolved before sterilized through a syringe 0.22μm PES syringe filter 
(Membrane Solution, USA) if added to cell culture. The 7,8-NP solution was kept on 
ice at all times and used immediately after preparation. 
E) 50% acetonitrile & 0.5% Triton X100 solution 
A 1% triton X100 solution was prepared by weighing out 1 g (
W
/V) in a schott bottle, 
and dissolved in 99 ml of nano-pure water before sonication to ensure the detergent 
had dissolved. A 100mL 1:1 ratio of 100% ACN : 1% triton X100 was vortexed 
briefly and placed on ice before being used. 
F) Propidium Iodide solution 
A 1 mg/mL stock solution of propidium iodide (Sigma-Aldrich Co. LLC, New 
Zealand) dye was prepared in nano-pure water and was kept in a sterilize schott 
bottle, wrapped in tin foil at 4C. 
G) D-Neopterin 
Neopterin stock solution (100µM) was prepared by dissolving D-neopterin powder 
(Schircks Laboratories, Switzerland) in AmPO4 pH6 by sonicating. The solution was 
stored at -20C in 200μL aliquots. 
H) Apocynin solution 
An apocynin stock solution was prepared by dissolving apocynin powder (Sigma-




solution was then filter-sterilized through a 0.22μM PES syringe filter (membrane 
Solutions, USA) and stored at 4C.  
I) Sodium Thiocyanate solution 
A sodium thiocyanate stock solution was prepared by dissolving sodium thiocyanate 
powder (Sigma-Aldrich) in RPMI 1640 without phenol red to give a concentration of 
2mM. The solution was then filter-sterilized through a 0.22μM PES syringe filter and 
stored at 4C.  
J) Phorbol 12-myristate 12-acetate (PMA) 
The PMA stock solution was prepared by dissolving PMA powder in DMSO to 
produce a 5mM solution. 20μL aliquots were pipetted into 1.7mL centrifuge tubes 
and stored at -20C. 
K) Acidic Iodide & ascorbic acid 
Powdered iodine (2.7g) and potassium iodide (5.4g) were dissolved into 35mL of 
nano-pure water. Concentrated HCl (4.37mL) was added to make the final volume up 
to 50mL. The solution contains 5.4% I2 / 10.8% KI in 1M HCl forming triodide (I3
-
 




(aq) + I2(aq)  
A 0.6M ascorbic acid solution was prepared by dissolving 1.057g in 10mL of nano-
pure water. The solution was prepared fresh each day and wrapped in aluminium tin 
foil to avoid light exposure as it can oxidize easily. 
2.2 Methods 
2.2.1 Cell Culture based research 
All cell culture was performed under aseptic conditions in a Class II biological safety 
cabinet (Clyde-Apex BH 200). All instruments and plasticware were either brought 
sterilized (Greiner, Greiner Bio-one, Neuburg, Germany) or been sterilized by 
autoclaving (15 min, 121C, 15 psi). All media and solutions added to cells were 
sterilized by autoclaving or by filtration through a 0.22μm membrane filter 
(Membrane Solutions, USA). The cells were kept at 37C in a humidified atmosphere 
calibrated to 5% carbon dioxide: 95% air (Sunnyo Electric Co. Ltd, Japan). All items 
were sprayed with 70% (
v




the Class II cabinet. Viable cells stained with trypan blue (1 part stain to 1 part cell 
solution) and counted on a haemocytometer slide using a light microscope. 
2.2.1.1 Cell Culture media 
Penicillin G (100units/mL), streptomycin (100g/mL) and 5% (
v
/v) foetal bovine 
serum (FBS) were combined with RPMI-1640 with glutamine media (with phenol 
red) for normal cell culture maintenance. 
2.2.1.2 U937 cell line preparation 
The U937 cell line was originally isolated from the pleural fluid of a 37-year old 
patient with generalized histiocytic lymphoma (Sundstrom and Nilsson, 1976). This 
cell line was chosen to study atherosclerosis as they adopt the morphology and 
characteristics of monocytes. The U937 cells used were a gift from the Haematology 
Research Laboratory at the Christchurch School of Medicine, University of Otago. A 
cryo-vial of cell culture was removed from liquid nitrogen storage and defrosted in a 
37ºC water-bath until almost thawed. The cell suspension was gently poured into a 
50mL centrifuge tube containing 20mL RPMI1640 and centrifuged at 1500 rpm for 
5minutes to remove the DMSO freezing media. The supernatant was discarded and 
the cell pellet was resuspended in 10 mL of RPMI 1640 media with FBS and 
penicillin/streptomycin and transferred to a 25cm
2
 tissue culture flask at 37C in a 5% 
CO2 humidified incubator. The cells were monitored daily and the density was 
counted via a haemocytometer to ensure the population was maintained between 0.3 – 
1.5 x 10
6 
cells/mL by passaging in Cellstar 75cm
2 
tissue culture flasks (Greiner Bio-
one) every 2-3 days.  
2.2.1.3 Cell experiment procedures 
The cells experiments were performed using Cellstar 12 or 24-well suspension 
culture plates (Greiner Bio-one), which prevent cells from sticking to the plate 
surface. Before each experiment, viable cells were counted using a haemocytometer, 
light microscope and the trypan blue exclusion assay to predict the cell density in the 
flask. The required quantity of cells for the experiment was pelleted by centrifugation 
at 500g for 5 minutes at room temperature and re-suspended in a calculated amount of 
RPMI-1640 (with or without phenol red) at 37ºC, to achieve a final concentration of 5 
x 10
5




experiment, maintaining the cell concentration per mL. Every experiment, unless 
stated otherwise, was performed in RPMI-1640 without phenol red and FBS to 
remove background colour interference with fluorescent techniques.  
2.2.1.4 Collection of human serum for culture media  
Donated blood was kept at room temperature for two hours for clotting to occur. The 
blood was then kept at 4ºC overnight to settle and to allow the human serum to 
separate from the clot. The serum was then transferred to 50mL centrifuge tubes using 
a 20mL syringe. The serum was centrifuged at 1000g for 15 minutes to pellet the red 
blood cells. The clear serum was then transferred to a new centrifuge tube, avoiding 
the transfer of any pelleted red blood cells. If the red blood cells were transferred 
over, the pelleting procedure was repeated. The serum was stored in 20mL aliquots at 
-80ºC for long-term storage, the aliquots were used up within 6 months. 
2.2.2 Low-density lipoprotein preparation & 
oxidation 
2.2.2.1 Blood collection and plasma preparation 
Collection of blood from donors and preparation of LDL from plasma was carried out 
under ethics approval Ethics Committee (CTY/98/07/069). The blood was collected 
by venipuncture from consenting healthy donors after an overnight fast. 200 mL of 
blood was collected from each donor into 50 mL tubes containing 0.5 mL of 
100mg/mL ethylene-diamine-tetra-acetic acid (EDTA). The tubes were centrifuged 
for 20 minutes at 4 ºC in a swing-out rotor at 2350 g. Plasma was transferred to 50 
mL round bottomed centrifuge tubes and centrifuged for 30 minutes at 11,000 g with 
slow acceleration/deceleration in a fixed angle rotor to remove any remaining cells. 
Plasma from all donors (5-6 at a time) was pooled to minimize the inter-individual 
variation (Gieseg 1994). The plasma was stored in 32 mL aliquots at -80 ºC for a 
maximum of 6 months. 
2.2.2.2 LDL purification from pooled plasma 
A 32 mL frozen tube of human plasma was left to defrost in running cold water and 
centrifuged at 47,000 rpm for 10 minutes at 4ºC to pellet any fibrinogen that had 




11.4g of potassium bromide (KBr) was slowly added to the plasma with gentle 
stirring with a magnetic flea. The final plasma density was 1.24 g/ml. The plasma was 
constantly kept on ice under argon gas until ultracentrifugation. Eight mL of 1mg/mL 
EDTA (pH 7.4) solution was added to 8 x OptiSeal
TM
 polyallomer centrifuge tubes 
(Beckman Coulter, USA). Using a long luer-fitting needle attached to a 10 ml syringe, 
4 ml of KBr-Plasma was placed in the bottom of the centrifuge tubes, underneath the 
EDTA solution.. The centrifuge tubes were balanced within 1% (0.01g) of each other 
and transferred to the NVTi-65, Beckman Near Vertical rotor and centrifuged at 
60,000 rpm for 2hours at 10ºC with slow acceleration/deceleration in OptimaTM L-
90K Preparative Ultracentrifuge (Beckman Coulter Inc, Fullerton, California). After 
centrifugation, a distinct layer of LDL appears in the density range of 1.019 - 1.063 
g/ml. LDL was extracted using a 90º needle attached to a 20 ml syringe. The extracted 
LDL was pooled into a 15 ml screw top centrifuge tube and flushed with argon gas 
and kept at 4ºC to prevent oxidation. 
2.2.2.3 LDL concentration determination and washing  
The LDL concentration was determined by measuring the total cholesterol content 
through an enzymatic reaction. The assay involves incubating 10µL of LDL with 1 
mL of cholesterol reagent (CHOL
TM
, Roche Diagnostics, Auckland, New Zealand) at 
room temperature for 10 minutes. The absorbance was read at 500nm against a blank 
containing cholesterol reagent. The LDL concentration was calculated from the 
absorbance, which is based on the estimate that cholesterol accounts for 31.69% of 
the entire LDL particle by weight and having a molecular weight of 2500 kDa. The 
LDL concentration value in the present study is the total mass of the apolipoprotein B 
(protein component of LDL) as 5:1 (Gieseg 1994). 
 
Calculating the LDL concentration 
Absorbance x 14.9 = [cholesterol] (mM) 
[cholesterol] (M) x 386.64 g/mol = [cholesterol] (g/L) 
[cholesterol] (g/L) x 100/31.69 = [LDL] (mg/mL) 
 
The LDL was buffer exchanged and concentrated using Amicon Ultra-15 filter 
tubes (Millipore, USA). The tubes were prepared by rinsing out with nano-pure water, 




tubes. The LDL was split equally between the two tubes, topped up with PBS and 
centrifuged at 3000 g for 30 minutes at 4ºC (fast acceleration/deceleration). Further 
centrifugation or addition of PBS was required to adjust the LDL concentration to 
~10mg/mL (total mass). 
2.2.2.4 Dialysis tubing preparation 
The dry dialysis tubing (Medical International, UK) with 14.4 mm width and 14,000 
Dalton molecular weight cut off were cut into 25 cm sections. The sections were 
boiled in a beaker with 5% (
w
/v) NaHCO3 and 1mM EDTA for 20 minutes. The 
sections were washed with nano-pure water and stored in 50% ethanol at 4ºC. 
Dialysis tubing was prepared by thoroughly rinsing with distilled water, followed by 
PBS. 
2.2.2.5 LDL oxidation 
Oxidized LDL (oxLDL) was prepared using the method of Gerry (2008). 
Concentrated LDL at ~10 mg/mL (total mass) was transferred into a section of the 
washed dialysis tubing. LDL was mixed with 0.5mM copper chloride (CuCl2) and the 
tubing was knotted on both ends with a 1.7mL centrifuge tube to prevent it from 
unraveling. The dialysis tubing was placed in a 2L bottle of 37ºC PBS containing 
0.5mM CuCl2 final concentration. The final volume of the PBS was adjusted 
according to the amount of LDL in the dialysis tubing, with 1L of PBS per 10mg of 
LDL protein. The bottle containing dialysis tubing was placed into an orbital shaker 
(Bioline, Edwards Instrument Company, Australia) at 37ºC for 24 hours. Incubating 
the yellow LDL solution with CuCl2 turns the LDL colourless, confirming that the 
oxidation had taken place. At the end of the incubation time, the dialysis tubing was 
transferred into 1L of 4ºC PBS containing a teaspoon of washed Chelex-100 resin and 
a large magnetic flea. The oxLDL was dialysed for 2 hours at 4ºC, constantly stirring 
to remove the free copper ions in solution. The dialysis tubing was then transferred to 
a fresh bottle of PBS with chelex-100 and stirred for a further 2 hours. The tubing was 
then transferred to a third bottle and dialyzed overnight. The dialysed oxLDL was 
removed out of the dialysis tubing via a mixing cannula and syringe, filter sterilized 




2.2.3 Cell viability assays 
2.2.3.1 Propidium iodide  
The viability of U937 cells after treatment was measured using propidium iodide (PI) 
staining and flow cytometer (BD Accuri
TM
 C6 flow cytometer, BD Biosciences, 
California, USA). PI intercalates between the DNA bases and fluoresces at an 
excitation wavelength of 535 nm and emission wavelength of 617 nm. PI is only able 
to intercalate the DNA of the cell when the cell membrane has been compromised 
during cell death. PI is used on the flow cytometer to evaluate cell viability and 
distinguish between necrotic, apoptotic and healthy cells. Analysis was performed 
using 250μL of the cell suspension incubated with 2μl of 1 mg/mL PI and mixing by 
gently inverting before incubating for 10 minutes in the dark. A set volume (30µL) 
was used to assess for cell viability on the flow cytometer using forward scatter (FSC) 
and the fluorescence filter FL-3 (FL-3). The cellular debris was excluded and the cell 
viability ratio (PI negative and PI positive cells) was compared with control and 
treatment samples. 
2.2.3.2 Trypan blue exclusion assay 
Trypan blue is a dye that selectively colours dead cells a distinctive blue by 
penetrating through the membrane. Viable cells have intact membranes and can 
actively pump out the dye so they are easily distinguishable from dead cells (Avelar-
Freitas 2014).  The assay was used to count viable cells in a 50 mL culture flask to 
assess the cellular density of the suspension. The flask was gently stirred and an 
aliquot of cell suspension was pipetted out of the flask into a 1.5 mL eppendorf tube. 
A 1:1 ratio of cell suspension: 0.4% trypan blue stain was added to the eppendorf and 
gently mixed with a pipette. The tube was left for 2 minutes to allow the dye to 
penetrate the cell membrane of any dead cells. A haemocytometer (Marienfeld, 
Germany) was used and a 10µL aliquot of the cell suspension with trypan blue. The 
ratio of stained and non-stained cells/mL of media was calculated to maintain the 
required density of cells in the flask otherwise cells were aliquoted from the flask and 




2.2.4 Determination of protein concentration 
The total cell lysate protein concentration was determined by using Pierce BCA 





by proteins in an alkaline medium. Two molecules of bicinchoninic 
acid (BCA) chelate one Cu
1+ 
ion, to form a purple dye. This chemical complex 
exhibits a strong absorbance at 562 nm on the spectrophotometer and the formation of 
purple dye is proportional to the protein concentration. The working reagent was 
prepared by mixing Reagent A (sodium carbonate, sodium bicarbonate, bicinchoninic 
acid, and sodium tartrate in 0.1 M sodium hydroxide) and Reagent B (4% hydrated 
copper sulphate) at a 50:1 ratio. 
Cell lysate samples were vortexed and diluted with nano-pure water by a factor of 2 
and 50µL of the sample was added to 1 mL of the working reagent. Samples were 
incubated on a heating block at 60ºC with gentle shaking for 30 minutes. The reaction 
was stopped by immediately transferring the samples to cold running water before 
reading the absorbance at 562 nm against a water blank. The protein concentrations 
were determined from a bovine serum albumin (BSA) standard curve with known 
concentrations between 0 – 250 µg/ml in 1 ml of the working reagent. The standard 
curve was analyzed by Prism (GraphPad Software, version 6.0, USA). 
2.2.5 Mitochondrial potential measurement with JC-1 
5’,6,6’-tetrachloro-1,1’,3,3’-tetraethylbenzimidazolylcarbocyanine iodide, commonly 
known as JC-1 is a cationic dye which accumulates within the mitochondria 
membrane and enables quantification of mitochondrial function. Healthy 
mitochondria exhibit a high mitochondrial potential through red-aggregation of the 
dye, however, the dye forms green monomers at low membrane potential. 
Mitochondria that exhibit a strong red fluorescence have a high mitochondrial 
potential whereas mitochondria that have a high green fluorescence have a low 
mitochondrial membrane potential. The intensity ratio between red:green fluorescence 
allows a comparative measurement of membrane potential inside the mitochondria 
against a particular toxin or uncoupler and determine if the mitochondria is 




A regular cell control is compared against a carbonyl cyanide 3-
chlorophenylhydrazone (CCCP) control that uncouples the proton gradient, 
depolarizing the mitochondria to allow standard compensation of the samples. 
After an experiment, 1mL of cell suspension were transferred to 1.7 ml centrifuge 
tube and spun at 500g for 5 minutes at room temperature. The cell pellet was washed 
once with warm PBS, resuspended in 500µL of RPMI-1640 without phenol red and 
incubated for 20 minutes with 1 µM JC-1 dye. The cells were pelleted and washed 
once with warm PBS and run through the flow cytometer for 10,000 viable gated 
events. Analysis of the results using the flow cytometer recorded the ratio between 
red fluorescence (FL-2 filter) and green fluorescence (FL-1 filter) to determine the 
mitochondrial membrane potential. 
2.2.6 Dihydroethidium (DHE) 
Dihydroethidium (DHE) is used to detect intracellular superoxide anions as measure 
for oxidative stress. The dye functions by reacting with superoxide anions in the 
cytoplasm resulting in the formation of ethidium (E
+
) which in turn binds to DNA and 
fluorescing red (excitation 510nm and emission 605nm). DHE (315.4 g/mol) 1mM 
stock solutions were prepared in DMSO and 50L aliquots were pipetted into 1.7mL 
centrifuge tubes and stored at -20C. After treatment, 400L of cell suspension was 
centrifuged at 1500rpm for 5 minutes. The supernatant was discarded and the cell 
pellet was resuspended in 200L of 10M DHE. After 20-minute incubation, the 
samples were run through the flow cytometer and analysed using the FL-2 mean 
fluorescence filter for 10,000 viable gated events. 
2.2.7 Plaque culture 
2.2.7.1 Endarterectomy plaque and patient plasma collection 
Plaque tissue (Figure 2.1) was collected from the Christchurch hospital, from patients 
undergoing a carotid endarterectomy procedure under the supervision of Prof. Justin 
Roake. The plaque samples were kept on ice until brought to the Free Radical 
Biochemistry laboratory. Under sterile conditions, (section 2.2.1) the plaque obtained 
was initially photographed (Canon EOS 76OD with an EFS 60mm f/2.8 macro USM 




were placed into 60 x 15mm polystyrene non-pyrogenic tissue culture dishes (Figure 
2.2) (Becton Dickinson Labware, Franklin Lakes, NJ, USA) and the weights of the 












Figure 2.1 Atherosclerotic plaque excised from carotid endarterectomy 
 
2.2.7.2 Live plaque culture procedure 
Under sterile conditions (Section 2.2.1), 2mL of RPMI 1640 with phenol red (10% 
human serum as discussed above in section 2.2.1.4 and penicillin G (100units/mL), 
streptomycin (100g/mL)) was added to each plate. Each dish was labelled according 
to the order in which the plaque sections were cut from the whole plaque and 
incubated for 24 hours at 37ºC. After the 24hour incubation, the media was removed 
using a 1mL pipette then stored in 1.7mL centrifuge tubes at -80 ºC with the 
appropriate incubation time. Plaque sections were incubated for a total of 96 hours, 
changing the media every 24 hours and storing the collected samples in the -80ºC for 
future analysis. After 96 hours, the plaque sections are removed from the dishes using 
forceps and stored in 1.7mL centrifuge tubes with parafilm around the cap and stored 

















Figure 2.2 Plaque Sections incubating in their corresponding plates 
 
2.2.7.3 PMA stimulation of live plaque 
The plaque sections had been incubated for 24 hours to wash the plaque and remove 
excess clot. The media was removed and the plaque was incubated for a further 24 
hours in media only to determine the baseline production of neopterin.  The media 
was removed and stored in 1.7mL centrifuge tubes at -80 ºC. 20mL of fresh media 
containing 5M PMA was aliqouted into the dish (2mL per dish) and incubated for a 
further 24 hours at 37 ºC. PMA was added 48 hours after the initial wash step and the 
media was kept and stored at -80ºC for future analysis. 
2.2.8 Lactate assay 
The lactate assay kit from Roche Diagnostics (Indianapolis, Indiana, USA) utilizes the 
concept of lactate oxidase (LOD), converting the substrate lactic acid into pyruvate 
and hydrogen peroxide. The peroxidase (POD) then catalyses the reaction of 
hydrogen peroxide and a hydrogen donor, in the presence of 4-aminoantipyrine 
(AAP), producing a purple chromogen. The intensity of the purple chromogen is 
directly proportional to the concentration of lactic acid present within the media. Live 
cells utilize glucose to produce lactic acid so the concentration of lactic acid in 
solution gives an indication of the metabolic state of the cells. The kit has two 
working reagents: Reagent 1 (R1) contains the hydrogen donor, ascorbate oxidase, 
buffers and preservatives, Reagent 2 (R2) contains AAP, lactate oxidase, horse 
peroxidase, buffers and preservatives. The assay total volume in this method has been 
reduced from the standard method volumes to allow for the reaction to take place in a 
250L 96 well plate. Reagent 1 (80uL) was combined with 20uL of sample or 




added to 35uL of R2 with 20uL of the diluted sample to give a 205uL total reaction 
volume. Each sample was run in duplicate and a microplate reader spectrophotometer 
(660nm absorbance wavelength) was used to analyse each sample. 
2.2.8.1 Lactate standard curve preparation 
The standard curve was prepared by diluting lactic acid with nano-pure water to seven 
standards between the 0.22 to 15.5mM kit detection limit. These standards were in 
duplicate using a 96 well plate along with two blanks, one blank with reagent 1 with 










Figure 2.3 Lactate standard curve 
 
2.2.9 Detection and analysis of pterin compounds 
Pterin analysis was conducted by using isocratic cation exchange high performance 
liquid chromatography (HPLC) with detectors measuring both fluorescence and 
UV/Vis absorbance at Ex 353/Em 438 nm, and 254 nm respectively (Lindsay 2014). 
Peak height and were determined by using Shimadzu software Postrun Analysis 
TM
 
version 1.22SP1, with peak area only used in analysis. HPLC analysis was conducted 
using two similar machines from Shimadzu 
TM
 Corporation, Japan. 
Shimadzu SCL 10A was equipped with a SCL-10A VP controller, RF-10AXL 
fluorescence detector (xenon lamp), LC-10AD solvent delivery system, SPD-10A 
UV-Vis detector (deuterium lamp), SIL-10A autoinjector with a CTO-10A column 
oven and DGU-14A on-line degasser. 
Shimadzu CBM 20A was equipped with a CBM-20A central bus module, LC-20AD 
solvent delivery module, SPD-M20A UV-Vis detector (deuterium lamp) detector, RF-























10AXL fluorescence detector (xenon lamp), SIL-20ACHT autoinjector with CTO-
20A column oven and DG-20 As degasser 
Ammonium phosphate buffer (pH 2.5) (Section 2.1.3 C) was run through a cation 
exchange LUNA 
TM
 SCX column (250 mm x 4.6 mm ID, 5µm column, Phenomenex, 
New Zealand) with 10% ACN as a mobile phase at 35ºC. The required concentration 
of 10% ACN (HPLC grade 100%) was mixed online at flow rate of 1mL/minute. The 
column utilizes the concept of cation exchange where the mobile phase passes over 
the stationary phase that is made up of negatively charged sulphonyl groups, which 
interact with positively charged molecules in the mobile phase at low pH. As 7,8-
dihydroneopterin has little or no natural fluorescence, the pterin assay utilizes the 
highly fluorescent oxidized form, neopterin.  
2.2.9.1 Preparation of cell culture samples for pterin assay 
After the required cell preparation had been achieved, the cell pellet was washed 
twice with warm PBS and resuspended in 300µL of 50% acetonitrile/0.5% triton 
X100. The samples were left for 5 minutes on ice to allow the cells to lysis and 
centrifuged at 17900 rcf for 5 minutes at 4ºC to pellet the proteins. 100µL of the 
sample’s supernatant was directly used for neopterin analysis while the 50µL of the 
remaining supernatant was left in the -20ºC freezer for BCA protein assay as 
mentioned above in section 2.2.4 protein determination. 
2.2.9.2 Preparation of plaque samples for pterin assay 
 
Neopterin 
A 50:50 ratio of defrosted samples (100µL) and ACN (100µL) were added in to a 
1.7mL centrifuge tubes and spun at 20,300g for 10 minutes at 4ºC. 100µL of the 
supernatant was loaded into HPLC vials and 10µL of this sample was injected into the 




7,8-NP is oxidized to the fluorescent neopterin using tri-iodide before HPLC analysis 
of neopterin. 100µL of the defrosted plaque media and cell lysates samples were 




sample was vortexed for five seconds then centrifuged at 20,300g for 10 minutes at 
4ºC. 40µL of acidic iodide solution was added, vortexed for five seconds and left to 
incubate at room temperature for 15 minutes. After the incubation time, 20µL of 0.6M 
ascorbic acid was added to reduce the iodine and stop the oxidation. This caused the 
sample to change from brown to clear. The samples were then centrifuged at 20,300g 
at 4ºC for 10 minutes before loading 100µL of sample into the HPLC vials. 10µL of 
the sample was injected into the HPLC for analysis. Each plasma sample was run in 
two separate duplicates to reduce error. 
 
2.2.10 Statistical analysis 
The results presented were graphed and statistically analysed by GraphPad Prism 
version 6.0 for Macintosh (GraphPad Software, San Diego, California, USA).   
Significance is confirmed by either, one-way or two-way analysis of variance 
(ANOVA). Significance levels are indicated as: (*) p  0.05, (**) p  0.01 and (***) 
p  0.001. Most results that are presented within this thesis are taken from a single 
experiment, which is representative of three separate experiments. The graphs are 
presented as the mean and the standard error of the mean (SEM) were calculated from 






















3.1  Toxicity of oxLDL  
 
3.1.1 The effect of oxLDL on the cell viability of U937 cells 
 
The research commenced with an investigation of the oxLDL induced toxicity in 
U937 cells, confirming previous findings that oxLDL can cause significant cell death. 
The toxicity of oxLDL to U937 cells was investigated by using the technique 
propidium iodide (PI) staining to determine the ratio of alive cells (PI negative) and 
cells undergoing necrosis (PI Positive) (Figure 3.1.1A). Cells were incubated for 24 
hours with increasing concentrations of oxLDL between 0.10mg/mL to 0.60mg/mL 
and cell viability was measured through PI staining. Results show that the median 
lethal dose to kill 50% of the cell population (LD50) was 0.18 mg/mL (Figure 
3.1.1A).  
 
Changes in cell morphology after oxLDL treatment was examined through a light 
microscope (Leitz Wetzlab Germany) (Figure 3.1.1B). The U937 cells in the absence 
of oxLDL showed the typical spherical cell morphology. Cells treated with 0.10 – 
0.20 mg/mL oxLDL showed a swelling of the plasma membrane with cellular debris 
present, signifying prominent cell death. OxLDL at 0.30 – 0.50 mg/mL caused 
significant cell death, displaying rupturing of the cells membrane and leaving behind 
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Figure 3.1.1 Effect of oxLDL on U937 cell viability using the Propidium Iodide. 
U937 cells (0.5x10
6
 cells/mL) were treated with increasing concentrations oxLDL and incubated at 
37ºC for 24 hours in non-phenol red RPMI-1640. A) Cell viability was measured by PI and the data 
was expressed as a percentage of the respective control (0mg/mL oxLDL). Results were analyzed by 
Flow Cytometry under the FL-3 filter. Significance is indicated from the cell only control. Results are 
displayed as mean ± SEM of triplicates from a single experiment, representative of three separate 
experiments. Significance levels are indicated as: (*) p  0.05, (**) p  0.01 and (***) p  0.001. B) 
Cells treated with varying concentrations of oxLDL were viewed in tissue culture plates through an 
inverted microscope (20x magnification) after 24hours. Images were taken using a LEICA DMIL 
microscope with a LEICIA DFC290 camera. 
Control 0.1mg/mL oxLDL 0.15mg/mL oxLDL 




3.1.2 7,8-NP protection against oxLDL toxicity 
 
It has been previously shown by this laboratory that 7,8-dihydroneopterin (7,8-NP), a 
water-soluble antioxidant, can provide protection to U937 cells against oxLDL 
toxicity (Gieseg 2001, Baird 2005). This experiment was to confirm the previous 
findings of 7,8-NP protecting the U937 cells from oxLDL. 
U937 cells were incubated with 0 – 200 M 7,8-NP for 10 minutes before being 
incubated with oxLDL. The results (Figure 3.1.2A) showed that the PI negative cells 
treated with 200M 7,8-NP had a significant increase in cell viability of up to 70% 
compared to cells that had been treated with 0 M 7,8-NP (oxLDL only control) with 
a decrease of 45% from the control . The 200µM 7,8-NP treatment provided the most 
protection to PI negative cells compared to lower concentrations of 7,8-NP 
treatments. The cell morphology was also examined after 7,8-NP and oxLDL 
treatment, under the light microscope (Figure 3.1.2B). The images show a 
considerable amount of cellular debris present in the oxLDL only control compared to 
cell only control. OxLDL treated cells showed an increase in cell count and a 
reduction in cellular debris with increasing concentrations of 7,8-NP. These results 
support the hypothesis that 7,8-NP does have a protective, concentration dependent 
effect on U937 cells treated with oxLDL by scavenging the intracellular oxidants 


















































Figure 3.1.2 Effect of 7,8-dihydroneopterin on oxLDL treated cells 
U937 cells (0.5x10
6
 cells/mL) were treated with increasing concentrations of 7,8-NP and 0.2mg/mL 
oxLDL and incubated at 37ºC for 24 hours in non-phenol red RPMI-1640. A) Cell viability was 
measured by PI and the data was expressed as a percentage of the respective control (0mg/mL oxLDL). 
Results were analyzed by Flow Cytometry under the FL-3 filter. Significance is indicated from the 
oxLDL control. Results are displayed as mean ± SEM of triplicates from a single experiment, 
representative of three separate experiments. Significance levels are indicated as: (*) p  0.05, (**) p  
0.01 and (***) p  0.001. B) Cells treated with various concentrations of 7,8-NP + oxLDL were 
viewed in tissue culture plates through an inverted microscope (20x magnification) after 24hours. 
Images were taken using a LEICA DMIL microscope with a LEICIA DFC290 camera. 
 
Control 0.2mg/mL oxLDL 
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3.2 Variability of oxLDL 
 
OxLDL is an extremely potent cytotoxic agent to U937 cells (Katouah 2015). 
However, there is a large variability in the level of toxicity to U937 cells between 
different batches prepared. The toxicity of each batch prepared was tested to 
determine the median lethal dose (LD50) and this concentration was used in 
subsequent experiments. The exact reason for this variability in toxicity is currently 
unknown, but is not due to varying levels of 7-ketocholesterol (Rutherford 2012). 
The variability of oxLDL toxicity to U937 cells was examined by incubating cells 
with two separate batches of oxLDL for 24 hours. The results are consistent to what 
was seen in Section 3.1. Analysis of Figure 3.2.1 A & B show that the standard LD50 
was between 0.15 – 0.20mg/mL. Problems were encountered with the oxLDL toxicity 
changing from the predetermined value. An oxLDL batch was prepared and an LD50 
experiment was conducted, the oxLDL toxicity had decreased the following week 
(Figure 3.2.2). The graph showed the LD50 for week 1 to be 0.05mg/mL however, the 
following week (week 2) the LD50 was 0.18mg/mL. This suggests that the unknown 
cytotoxic agent had decayed over the week when left at 4ºC. 
 
Further research investigated the effect of washing a batch of oxLDL and testing the 
LD50 before and after the wash steps. This was achieved by preparing a fresh batch of 
oxLDL and using chelexed PBS (pH 7.4) to dilute the oxLDL to 50mL and using 
filtered centrifuge tubes to separate the PBS and oxLDL. The oxLDL’s concentration 
was retested via the cholesterol assay, followed by a LD50 retest. The results (Figure 
3.2.3) show that before the oxLDL was washed, the LD50 was 0.12mg/mL however, 
after the PBS washing the LD50 concentration increased to 0.30mg/mL. This suggests 
that there are cytotoxic agents present in the oxLDL that can be removed through 
further PBS wash steps. 
 
The results suggested that in this research, during the oxLDL washing steps, it is 
essential that good dialysis methods are used to effectively remove the cytotoxic 
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Figure 3.2.1 Comparison of U937 cell viability between two separate oxLDL 
preparations 
A) OxLDL batch was prepared on 3.3.15 and B) a separate oxLDL batch was prepared on 29.9.15. 
U937 cells (0.5x10
6
 cells/mL) were treated with increasing concentrations oxLDL from the 
corresponding batch and incubated at 37ºC for 24 hours in non-phenol red RPMI-1640. Cell viability 
was measured by PI and the data was expressed as a percentage of the respective control (0mg/mL 
oxLDL). Results were analyzed by Flow Cytometry under the FL-3 filter. Significance is indicated 
from the cell only control. Results are displayed as mean ± SEM of triplicates from a single 
experiment. Significance levels are indicated as: (*) p  0.05, (**) p  0.01 and (***) p  0.001. 
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Figure 3.2.2 Loss of oxLDL toxicity after over time 
U937 cells (0.5x10
6
 cells/mL) were treated with increasing concentrations oxLDL (prepared on 8.9.15) 
and incubated at 37ºC for 24 hours in non-phenol red RPMI-1640. Cell viability was measured by PI 
and the data was expressed as a percentage of the respective control (0mg/mL oxLDL). Results were 
analyzed by Flow Cytometry under the FL-3 filter. Significance is indicated from the cell only control. 
Results are displayed as mean ± SEM of triplicates from a single experiment Significance levels are 





















Figure 3.2.3 Effect of PBS-washed oxLDL on U937 cell viability 
U937 cells (0.5x10
6
 cells/mL) were treated with increasing concentrations oxLDL (prepared on 
10.2.16) and incubated at 37ºC for 24 hours in non-phenol red RPMI-1640. Cell viability was 
measured by PI and the data was expressed as a percentage of the respective control (0mg/mL oxLDL). 
Results were analyzed by Flow Cytometry under the FL-3 filter. Significance is indicated from the cell 
only control. Results are displayed as mean ± SEM of triplicates from a single experiment. 




3.3  Oxidative stress induced by oxLDL 
 
 
There is a substantial amount of evidence that implicates oxidative stress in the 
development and progression of atherosclerosis through an overproduction of 
oxidants generated within the cell (Madamanchi 2005, Goncharov 2015). Previously 
it has been found that oxLDL induces an over production of superoxide that results in 
a dramatic loss in glutathione (GSH) and cell viability (Gieseg 2010 B, Katouah 
2015). In this section, the oxidative stress induced by oxLDL in U937 cells was 
investigated by using intracellular superoxide fluorescent probe, dihydroethidium 
(DHE). Additionally the oxLDL-induced oxidation of intracellular 7,8-NP was 
investigated through HPLC analysis. 
 
 
3.3.1 The effect of oxLDL on intracellular oxidant production in 
U937 cells 
 
A time course study was conducted to determine the effect of oxLDL on the 
intracellular oxidative stress in U937 cells when exposed to sub-lethal concentrations. 
The cells were treated with a sub lethal 0.20 mg/mL oxLDL followed by probing with 
DHE at 0, 1, 2, 3, 4 and 6 hours and the mean cellular fluorescence was analyzed via 
flow cytometry. The cells treated with oxLDL showed a gradual increase in mean 
cellular fluorescence between 0 – 6 hours, reaching a 50% increase from the 0 hour 
control (Figure 3.3.1). This confirms the finding that oxLDL is inducing a significant 
increase of intracellular superoxide, which is thought to cause significant damage to 


























 cells/mL) were treated with 0.20mg/mL of oxLDL and incubated at 37ºC in non-
phenol red RPMI-1640. At various time points, the cells were washed and stained with DHE for 
20minutes in the dark to measure the intracellular superoxide production from oxLDL. The cells were 
measured by Flow Cytometry under the FL2 filter and the data was expressed as a percentage increase 
of the 0 hour control. Significance is relative to the 0-hour control and results are displayed as mean ± 
SEM of triplicated from a single experiment, representative of three separate experiments. Significance 





As previously discussed in section 3.1, 7,8-NP has antioxidant properties that 
partially protect viable cells from undergoing cell death by scavenging the 
intracellular oxidants generated by oxLDL.  
The hypothesis was further explored by using DHE probing on U937 cells exposed to 
both oxLDL and 7,8-NP, to confirm if the intracellular superoxide production would 
be reduced with the presence of 7,8-NP. The results (Figure 3.3.2) showed a 70% 
increase in mean cellular fluorescence of the oxLDL only treatment compared to the 
cell only control. The treatment with oxLDL and 200µM 7,8-NP showed a 15% 
increase in mean cellular fluorescence compared to the cell only control. The results 
show that treatments with 7,8-NP had a significantly lower DHE staining compared to 
oxLDL. This indicates that 7,8-NP is scavenging the intracellular superoxide anions 
produced when U937 cells are exposed to oxLDL. 
 
 
   
 












































































Figure 3.3.2 Intracellular superoxide production in U937 cells when exposed to 
oxLDL and 200µM 7,8-NP.  
U937 cells (0.5x10
6
 cells/mL) were treated with 0.2mg/mL of oxLDL + 200µM 7,8-NP and incubated 
at 37ºC in non-phenol red RPMI-1640. At the 6 hour time point, the cells were washed and stained 
with DHE for 20 minutes in the dark to measure the intracellular superoxide production from oxLDL. 
The cells were measured by Flow Cytometry under the FL2 filter and the data was expressed as a 
percentage increase of the 0 hour control. Significance is relative to the 0-hour control and results are 
displayed as mean ± SEM of triplicated from a single experiment, representative of three separate 
experiments. Significance levels are indicated as: (*) p  0.05, (**) p  0.01 and (***) p  0.001. 
 
Further research investigated the intracellular oxidation of 7,8-NP when U937 cells 
were incubated with oxLDL. Before this research could take place, appropriate 
experiments had to be carried out to determine the minimum concentration of triton 
X100 required for 100% of the cells to lyze and ensure the triton X100 detergent 
would not affect the neopterin elution time or the peak area. The minimum triton 
X100 concentration was determined by incubating various concentrations between 0 – 
0.5% for 10 minutes then determining the cell viability through light microscope. Cell 
images (Figure 3.3.3) of the triton X100 treatments showed that 0.05% triton X100 
was the minimum concentration required to lyze 100% of the viable cells.  
 
Determining the effect of 50% acetonitrile in the injected sample (not the mobile 
phase) on the neopterin peak area was done by mixing a 100nM neopterin standard 
with either ammonium dihydrogen phosphate or 50% acetonitrile and injecting them 
into the HPLC. Ammonium dihydrogen phosphate is the standard media used in 
pterin analysis on the HPLC (Section 2.2.6.1), therefore acts as an effective reference 
point to determine whether the 50% acetonitrile in the sample was altering the peak 
area of the neopterin standard. According to Figure 3.3.4, there was no significant 
difference between ammonium dihydrogen phosphate or 50% acetonitrile neopterin 






























































































Figure 3.3.3 Cell images of U937 cells incubating with 0 – 0.5% triton X100. 
U937 cells (0.5x10
6
 cells/mL) were treated with 0 – 0.5% triton X100 and incubated at 37ºC in non-
phenol red RPMI-1640 for 10 minutes. Cells were viewed in tissue culture plates through an inverted 
microscope (20x magnification). The images were taken using a LEICA DMIL microscope with a 
















Figure 3.3.4 Comparison of AmPO4 vs ACN Media on neopterin peak area using 
HPLC. 
100nM neopterin standard was made up in either 50% acetonitrile or 20mM ammonium phosphate 
dibasic (AmPO4). Five samples of each treatment were run through the HPLC to determine the effect 
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The second experiment was to determine if the non-ionic detergent, triton-X100, 
would affect the neopterin peak area. A 100nM neopterin standard was mixed with 
50% acetonitrile or 50% acetonitrile + 0.5% triton X-100.  The results showed no 
notable difference in the elution time of neopterin (Figure 3.3.5A) or peak area 
(Figure 3.3.5B) between both treatments. This confirmed that the non-ionic detergent 
was not interfering with the column side-chains and altering the neopterin elution 
time or peak area. Therefore 0.5% triton X100 in 50% acetonitrile was used because it 
effectively lyzed and acetonitrile precipitated the soluble proteins in solution while 




















Figure 3.3.5 The effect of 0.5% Triton-X100 on neopterin peak area using 
HPLC. 
Fluorescence (Ex 353/Em 438 nm) chromatograms (1, 2 & 3) of 100nM neopterin standards with either 
1 (ACN only), 2 (100nM Neopterin + 50% ACN) or 3 (100nM Neopterin + 50% ACN + 0.5% Triton 
X100). A) Samples were run through the HPLC to determine the effect of triton x100 on the neopterin 
peak area.  B) Results were displayed as mean ± SEM of the peak area which is directly proportional to 
the concentration. Samples were run in triplicate and ND represents not detected. 
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7,8-NP protection of U937 cells against oxLDL mediated oxidative stress has been 
extensively studied in our lab, however, in vitro neopterin production has not been 
investigated. This part of the study focused on measuring the intracellular neopterin 
produced when U937 cells were exposed to oxLDL. This was done by preloading 
U937 cells with 7,8-NP for 10 minutes before oxLDL exposure for 0, 1, 3, 6 and 12 
hours. The treated cells were incubated with 0.5% triton X-100 and placed on ice for 
10 minutes before addition of 50% acetonitrile. The cell lysates were injected into the 
HPLC for analysis for intracellular neopterin. The cell images were taken at 0 hours 
(Figure 3.3.6A) and after 12 hours exposure (Figure 3.3.6B). Prominent cell death 
was seen after 12 hours of oxLDL exposure, by the disturbance of the plasma 
membrane and cellular debris. The cells show a swelling of the cell membrane and do 
not show the typical nuclear condensation characteristic of apoptosis, suggesting the 
cells were undergoing a necrotic cell death. Analysis of the HPLC fluorescence 
chromatograms (Ex 353/Em 438 nM) shows a significant increase of intracellular 
neopterin peak area when cells had been incubated with oxLDL and 7,8-NP (6.7 
nmoles/mg cell protein) for 12 hours (Figure 3.3.7B) compared to 0hr oxLDL treated 
cells (1.5 nmoles/mg cell protein) (Figure 3.3.7A). The cell lysate samples were run 
coincide with neopterin standards to ensure that the retention time of 5.4 minutes was 
neopterin. The third peak with an elution time of 7.1 (Figure 3.3.7A) and 6.5 (Figure 
3.3.7B) is thought to be intracellular 7,8-NP.  The results (Figure 3.3.8) show that 
oxLDL treated cells had a significantly higher neopterin production at 6 and 12 hours 
than the 7,8-NP only treatment. This confirms that oxLDL exposure generates 








Figure 3.3.6 Images of U937 cells after 0 and 12 hours of oxLDL treatment 
Images of U937 cells after incubation with 0.2mg/mL oxLDL for 0 hours (A) and 12 hours (B). The 
images were taken using a LEICA DMIL microscope with a LEICIA DFC290 camera. The population 
density is at 500,000 cells per mL. After 12 hours incubation (B) there is significant cell death and 
cellular debris present that is not seen at 0 hour. 


















Figure 3.3.7 Fluorescence chromatograms of intracellular neopterin peak 
generated from U937 cells with oxLDL for 12 hours. 
Fluorescence (Ex 353/Em 438 nm) chromatograms (A, B) of intracellular neopterin from U937 cells, 
preincubated with 200µM 7,8-NP before the addition of 0.2mg/mL oxLDL for 0 – 12 hours. B 

























Figure 3.3.8 Intracellular neopterin production in U937 cells incubated with 7,8-





) in RPMI were incubated with 200µM 7,8-NP, followed by addition 
(dotted line) or absence (filled line) of 0.2mg/mL oxLDL. Cell lysates were collected at indicated times 
and analyzed for intracellular neopterin via HPLC. Protein was determined via BCA assay. Results are 
displayed as mean ± SEM in triplicate and significance is indicated from the 7,8-NP baseline (filled 
line) from the corresponding time point. Significance levels are indicated as: (*) p  0.05, (**) p  0.01 
and (***) p  0.001. 
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NOX is thought to play a significant role in the production of intracellular oxidants 
when cells are exposed to oxLDL, apocynin was utilized as a tool to reduce the 
intracellular oxidation of 7,8-NP, through inhibition of NOX. This experiment was 
following on from the previous results of observing oxLDL-induced 7,8-NP 
oxidation. This was achieved by preincubating U937 cells with 200µM 7,8-NP and 
20µM apocynin for 10 minutes before the addition of 0.20mg/mL oxLDL and 
incubated for 0, 1, 3, 6 and 12 hours. The treated cells were incubated with 0.5% 
triton X-100 and placed on ice for 10 minutes before addition of 50% acetonitrile. The 
cell lysates were injected into the HPLC for analysis for intracellular neopterin. The 
neopterin produced by the cell lysates were standardized via flow cytometry, to 
determine the amount of cells in each sample and to compensate for cell death or 
growth during the 12 hour incubation. The flow cytometry method was used in this 
experiment instead of the BCA protein assay due to the convenience and reduced the 
time taken for sample preparation. 
 
Analysis of the HPLC fluorescence chromatograms (Ex 353/Em 438 nM) showed  
the significant increase of neopterin production in the oxLDL 12 hour treatment of 
13.8 pmoles/500,000 cells (Figure 3.3.9B) compared to the control 12 hour treatment 
of 8.0 pmoles/500,000 cells (Figure 3.3.9A). Interestingly, the oxLDL + apocynin 12 
hour treatment showed a decrease in neopterin production to 7.6 pmoles/500,000 cells 
(Figure 3.3.9C).  
 
The results from Figure 3.3.10 show a significant increase of intracellular neopterin 
in the oxLDL + 7,8-NP (red dotted line) treatment after 1 and 3 hours although the 
neopterin started to decrease after 6 hours and then plateaued at 12 hours. The oxLDL 
treatment showed a significant increase of intracellular neopterin compared to the 7,8-
NP control (blue solid line). This confirms that oxLDL induces significant 
intracellular oxidative stress compared to basal level (Figure 3.3.10). The oxLDL + 
7,8-NP + apocynin (green dotted line) showed a significant decrease of intracellular 
neopterin after 6-12 hours. This suggests that the apocynin requires an incubation 
















    
 
 
Figure 3.3.9 Fluorescence chromatograms of intracellular neopterin peak 
generated from U937 cells with oxLDL and apocynin for 12 hours.  
Fluorescence (Ex 353/Em 438 nm) chromatograms (A, B and C) of intracellular neopterin from U937 
cells, preincubated with 200µM 7,8-NP before the addition of 0.20mg/mL oxLDL or 20µM apocynin 
for 0 – 12 hours. B neopterin peak increases significantly compared to A and C, indicating that 





















Figure 3.3.10 Intracellular neopterin production in U937 cells exposed to oxLDL 
and apocynin.  
U937 cells (100x10
4
 cells/mL) in RPMI were incubated with 200µM 7,8-NP, followed by addition 
(dotted red line), absence (filled blue line) of 0.20mg/mL oxLDL or 20µM apocynin + oxLDL (double 
dotted green line). Cell lysates were collected at indicated times and analyzed for intracellular 
neopterin via HPLC. Neopterin values were standardized by cell count performed on the Flow 
cytometer. Results are displayed as mean ± SEM in triplicate and significance is indicated from the 
7,8-NP + oxLDL (dotted red line) from each corresponding time point. Significance levels are 
indicated as: (*) p  0.05, (**) p  0.01 and (***) p  0.001. 
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3.4    NADPH Oxidase (NOX) 
 
As previously shown in section 3.2, there was a significant increase of intracellular 
superoxide and a decrease of cell viability of U937 cells. Oxidant production and cell 
death are thought to be major driving factors of prolonged inflammation and 
progression of atherosclerotic lesions (Madamanchi 2005, Goncharov 2015, Katouah 
2015). However, the major source of the intracellular oxidative stress and the 
mechanism by which the oxLDL is triggering the cell to produce an exaggerated 
amount of oxidants is currently unknown. NOX is a membrane bound enzymatic 
complex that is used by immune cells to generate superoxide anions to eliminate 
pathogens. It was hypothesized that NOX is the major contributor of oxidant 
production when U937 cells are exposed to oxLDL.  The following studies were 
designed to implicate NOX in the oxLDL-induced oxidative stress and restore cell 
viability when the oxidative stress has been inhibited. The effect of gp91ds-tat (NOX 
inhibitor) on the superoxide production when U937 are exposed to oxLDL was 
extensively studied in this section. 
 
3.4.1 The effect of gp91ds-tat on the cell viability of U937 cells 
Initial experiments examined the concentration dependent effect of gp91ds-tat on the 
cell viability and ensure that cell death was not attributed to the inhibition of NOX. 
U937 cells were incubated with increasing concentrations of gp91ds-tat for 24 hours 
and cell viability (PI positive and PI negative stained cells) were measured via PI 
staining. The results (Figure 3.4.1) showed that 0 – 0.5µM gp91ds-tat did not 
significantly reduce the cell viability, implying that this concentration range did not 
induce a cytotoxic effect. The 1µM treatment showed no significant change in PI 
negative cells compared to the cell only control, however, there was a significant 3% 
increase of PI positive cells, suggesting a slight cytotoxic effect. The 2µM gp91ds-tat 
treatment showed a significant 15% reduction in PI negative cells and a significant 
20% increase of PI positive cells, suggesting that the 2µM gp91ds-tat is inducing a 
cytotoxic effect on the cell viability. This was confirmed in the cell photos (Figure 

















Figure 3.4.1 The effect of increasing concentrations of gp91ds-tat (NOX-2 
inhibitor) on PI cell viability in U937 cells. 
U937 cells (0.5x10
6
 cells/mL) were treated with increasing concentrations of gp91ds-tat and incubated 
at 37ºC for 24 hours in non-phenol red RPMI-1640. Cell viability was measured by PI and the data was 
expressed as a percentage of the respective control (cell only control). Results were analyzed by Flow 
Cytometry under the FL-3 filter. Significance is indicated from the cell only control. Results are 
displayed as mean ± SEM of triplicates from a single experiment, representative of three separate 






















Figure 3.4.2 Cell images of increasing concentration of gp91ds-tat 
Images of U937 cells after incubation with 0 – 2µM gp91ds-tat for 24 hours. The images were taken 
using a LEICA DMIL microscope with a LEICIA DFC290 camera. The population density is at 
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3.4.2 The effect of gp91ds-tat on the superoxide production in U937 
cells 
The experiments in this section examined the effect of gp91ds-tat on the superoxide 
generation in oxLDL exposed U937 cells. Cells were incubated with different 
concentrations of gp91ds-tat for 1 hour before the addition of oxLDL, followed by 
DHE staining. Proceeding experiments investigated the effect of gp91ds-tat on the 
cell viability (PI positive and PI negative stained cells) when reducing the 
intracellular oxidative stress. 
 
U937 cells treated with 0.25mg/mL oxLDL for 6 hours (Figure 3.4.3) showed a 35% 
increase of mean cellular fluorescence compared to the cell only control, distinctly 
showing that the oxLDL is inducing a significant oxidative burst within the cell. Cells 
that had been treated with 0.2, 0.4, 0.5µM gp91ds-tat and oxLDL showed a 
significant 15, 18 and 25% decrease in mean cellular fluorescence respectively. This 
suggests that NOX has a significant role in the oxidant generation, largely 
contributing to the cytosol oxidative stress initiated by oxLDL. However, the inhibitor 
did not restore the cell viability as expected (Figure 3.4.4). This suggests that the 
remaining 10% of oxidative stress is causing the decrease in cell viability or another 
mechanism is occurring parallel to the oxidative stress mechanism, initiating cell 
death. It may also suggest that the DHE probe is significantly under measuring the 




























Figure 3.4.3 Oxidant production in U937 cells when exposed to 0.25mg/mL 
oxLDL and gp91ds-tat. 
U937 cells (0.5x10
6
 cells/mL) were treated with 0.25mg/mL of oxLDL and incubated at 37ºC in non-
phenol red RPMI-1640. At 6 hour time point, the cells were washed and incubated with 10µM DHE for 
20minutes in the dark to measure the intracellular superoxide production from oxLDL. The cells were 
measured by Flow Cytometry under the FL2 filter. The data is displayed in triplicate mean ±SEM and 
as a percentage increase of the cell only control. Significance is a two-way ANOVA, relative to the 
0µM gp91 + oxLDL control. Significance levels are indicated as: (*) p  0.05, (**) p  0.01 and (***) 
p  0.001. 
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Figure 3.4.4 The effect of oxLDL and increasing concentrations of gp91ds-tat on 
cell viability in U937 cells. 
U937 cells (0.5x10
6
 cells/mL) were treated with increasing concentrations of gp91ds-tat and incubated 
with 0.25mg/mL oxLDL for 24 hours in non-phenol red RPMI-1640. Cell viability was measured by PI 
and the data was expressed as a percentage of the respective control (cell only control). Results were 
analyzed by Flow Cytometry under the FL-3 filter. Significance is indicated from the oxLDL only 
control (0µM gp91). Results are displayed as mean ± SEM of triplicates from a single experiment, 
representative of three separate experiments. NS = not significant. Significance levels are indicated as: 
(*) p  0.05, (**) p  0.01 and (***) p  0.001. 































































U937 cells were incubated with the same concentrations of gp91ds-tat for 1 hour 
before the addition of lethal concentration of oxLDL (0.40mg/mL), followed by DHE 
staining. The results (Figure 3.4.5) showed a significant 85% increase in mean 
cellular fluorescence compared to the cell only control. Treatments with 0.2 – 0.5µM 
gp91ds-tat + oxLDL showed a significant decrease in mean cellular fluorescence, 
with the same trend as seen in Figure 3.4.3. Cells treated with 0.2, 0.4 and 0.5µM 
gp91ds-tat showed a 25%, 45% and 55% (respectively) reduction in mean cellular 
fluorescence compared to the oxLDL only control. This suggests that increasing 
gp91ds-tat concentrations are inducing a significant reduction in superoxide 
generation.  
 
Cells with the same concentrations of gp91ds-tat and 0.40mg/mL oxLDL were 
incubated for 24 hours and the cell viability were measured by PI flow cytometry 
assay. Results (Figure 3.4.6) showed that gp91ds-tat provided no protection of the 
cell viability at a higher oxLDL concentration. There was a 85% decrease of PI 
negative cells and a 70% increase of PI positive cells in all of the oxLDL treatments. 
This suggests that even at the highest gp91ds-tat concentration (0.5µM) the U937 
cells are still exposed to a remaining 30% oxidative stress (Figure 3.4.5) with 
significant cell death occurring (Figure 3.4.6). These results are in agreement to what 





























Figure 3.4.5 Oxidant production in U937 cells when exposed to 0.40mg/mL 
oxLDL and gp91ds-tat. 
U937 cells (0.5x10
6
 cells/mL) were treated with 0.4mg/mL of oxLDL and incubated at 37ºC in non-
phenol red RPMI-1640. At 6 hour time point, the cells were washed and incubated with 10µM DHE for 
20 minutes in the dark to measure the intracellular superoxide production from oxLDL. The cells were 
measured by Flow Cytometry under the FL2 filter. The data is displayed in triplicate mean ±SEM and 
as a percentage increase of the cell only control and significance is a two-way ANOVA, relative to the 
0µM gp91 + oxLDL control. Significance levels are indicated as: (*) p  0.05, (**) p  0.01 and (***) 



















Figure 3.4.6 The effect of oxLDL and increasing concentrations of gp91ds-tat 
(NOX-2 inhibitor) on cell viability in U937 cells. 
U937 cells (500,000 cells/mL) were incubated with 0.4mg/mL oxLDL and increasing concentrations of 
gp91ds-tat (0, 0.4, 0.5µM) for 24 hours to determine the effect on the cell viability. Cell viability was 
measured by PI and the data was expressed as a percentage of the control. The different treatments 
were aliquoted into centrifuge tube and PI stain was added and incubated for 10 minutes in the dark. 
Results were analyzed by Flow Cytometry under the FL-3 filter. The data is displayed in triplicate 
±SEM. Significance was a two-way ANOVA and is indicated from the oxLDL control (0µM gp91). 
Significance levels are indicated as: (*) p  0.05, (**) p  0.01 and (***) p  0.001. 
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3.5   Mitochondria 
 
The mitochondria has been implicated as a potential source of oxidative stress when 
U937 cells are exposed to oxLDL. It is unknown if oxLDL is directly causing the 
mitochondria to release superoxide into the cell or if other sources of oxidative stress 
are damaging the mitochondria causing a secondary source of superoxide. This 
research focused on investigating this theory by utilizing a mitochondrial specific 
fluorescent dye called JC-1 and investigating the mitochondria membrane potential 
when U937 cells were incubated with oxLDL. Further research looked at using 7,8-
NP as a tool to determine if the loss in in membrane potential was a result of oxidative 
stress. The JC-1 technique measures the fluorescence measured from two filters, red 
(FL2) and green (FL1). The results were displayed as a ratio of red:green fluorescence 
and a significant reduction in the ratio indicates a loss in mitochondrial membrane 
potential. A control treatment incubated with carbonyl cyanide m-chlorophenyl 
hydrazine (CCCP) was used to equalize the membrane potential, establishing the 
lowest potential the membrane can dissipate to. 
 
3.5.1 The effect of oxLDL on U937 cells mitochondrial membrane 
potential 
Initial research investigated the effect of oxLDL on the mitochondria membrane 
potential by treating U937 cells with 0.20mg/mL oxLDL for 0, 2, 4, 6 and 8 hours 
followed by JC-1 staining. The FL2:FL1 ratio (Figure 3.5.1A) showed a small 
decline in membrane potential at 2 and 4 hours (3 & 15% respectively) and a 
significant depolarization at 6 and 8 hours (38 & 44% respectively). The LD50 
concentration (0.20mg/mL) showed a slow, gradual decrease in membrane potential 
over the course of 8 hours. The decrease in membrane potential at 6 hours suggests 
the oxLDL is inducing a cytotoxic effect to the mitochondria; however, the difference 
between the 8-hour treatment and the CCCP control suggests the oxLDL is inducing a 
































Figure 3.5.1 The effect of the mitochondrial membrane potential on U937 cells 
when exposed to 0.20mg/mL oxLDL for 0, 2, 4, 6, and 8 hours.   
U937 cells (1,000,000 cells/mL) were incubated with 0.25mg/mL oxLDL and samples were taken after 
0, 2, 4, 6 and 8 hours. Cells were washed and incubated with 100µM JC-1 for 20minutes. Results were 
analyzed by Flow Cytometer using the FL1,FL2 filter. A) Results are presented as a ratio of Red:Green 
fluorescence and in triplicate ±SEM. Significance was a one-way ANOVA and is indicated from the 0 
hour oxLDL exposed control. Significance levels are indicated as: (*) p  0.05, (**) p  0.01 and (***) 








































































The next experiment focused on the effect of a higher concentration (0.40mg/mL) of 
oxLDL on the membrane potential by incubating with oxLDL for 0, 1, 3, 6 and 24 
hours followed by JC-1 staining. Due to Figure 3.5.1 yielding a small cytotoxic effect 
to the mitochondrial at 0.25mg/mL, the mitochondria was subjected to a more lethal 
concentration of oxLDL (0.40mg/mL). 
The results (Figure 3.5.2A) showed a more prominent cytotoxic effect occurring, 
resulting in a loss of membrane potential over the 24-hour period. There was a slight 
decrease in membrane potential at 3 hours (36%), followed by a significant 
depolarization at 6 and 24 hours (56 & 69% respectively) compared to the 0 hour 
control. There was a small difference between the 24-hour treatment and the CCCP 
control, suggesting that 24-hour oxLDL exposure caused extensive membrane 
potential dissipation. Interestingly, there was a substantial 26% decrease in membrane 
potential between the cell only control and the 0-hour oxLDL exposure. There was 
virtually no difference between the cell only or the 0 hour oxLDL control groups 
except a 30 minute oxLDL exposure before analysis. This suggests that at high 
oxLDL concentrations, there is an instantaneous decrease in mitochondrial membrane 





















































Figure 3.5.2 The effect of the mitochondrial membrane potential on U937 cells 
when exposed to 0.40mg/mL oxLDL for 0, 3, 6 and 24 hours. 
U937 cells (1,000,000 cells/mL) were incubated with 0.4mg/mL oxLDL and samples were taken after 
0,3,6 and 24 hours. Cells were washed and incubated with 100µM JC-1 for 20minutes. A) Results are 
presented as a ratio of Red:Green fluorescence and in triplicate ±SEM. Significance was a one-way 
ANOVA and is indicated from the 0 hour oxLDL exposed control. Significance levels are indicated as: 
(*) p  0.05, (**) p  0.01 and (***) p  0.001. B) Represents the dot plots of 10,000 individual gated 





































































3.5.2 The effect of increasing oxLDL concentration on U937 cells 
mitochondria membrane potential 
Previously it was seen that 6-hour oxLDL exposure induced a significant decrease in 
membrane potential, therefore this research investigated the effect of increasing 
oxLDL concentration on the mitochondrial membrane potential at 6 hours exposure. 
U937 cells were incubated with 0 – 0.50mg/mL oxLDL for 6 hours and the membrane 
potential was analyzed. The results (Figure 3.5.3A) showed no decrease in membrane 
potential when incubated with 0 – 0.20mg/mL oxLDL, however, there was a 
significant decrease occurring at 0.30, 0.40 and 0.50mg/mL oxLDL (26, 33 and 52% 
respectively). This suggests that there is a proportional decrease in mitochondria 
membrane potential with increasing concentrations of oxLDL. In comparison to the 
CCCP and cells only control, the state of the mitochondria membrane potential was 
still relatively intact as the 0.50mg/mL treatment did not depolarize to the CCCP 
baseline. Further research investigated the effect on cell viability (Figure 3.5.4) of 
increasing oxLDL concentrations by PI staining. The 0.40mg/mL treatment showed 
85% PI negative cells remaining with an 18% increase of PI positive cells. 
Contrasting with 0.50mg/mL oxLDL showed a 60% decrease of PI negative cells and 
a 50% increase of PI positive cells. This suggests that significant cell death is 















































Figure 3.5.3 The effect of mitochondrial membrane potential on U937 cells when 
exposed to increasing concentrations of oxLDL for 6 hours. 
U937 cells (1,000,000 cells/mL) were incubated with 0-0.5mg/mL oxLDL for 6 hours. Cells were 
washed and incubated with 100µM JC-1 for 20 minutes. A) Results are presented as a ratio of 
Red:Green fluorescence and in triplicate ±SEM. Significance was a one-way ANOVA and is indicated 
from the 0 hour oxLDL exposed control. B) Represents the dot plots of 10,000 individual gated cells 











































































Figure 3.5.4 The effect of increasing oxLDL concentration on cell viability 
U937 cells (1,000,000 cells/mL) were incubated with 0-0.5mg/mL oxLDL for 6 hours. Cell viability 
was measured by PI and the data was expressed as a percentage of the control with no oxLDL. The 
different treatments were aliquoted into centrifuge tube and PI stain was added and incubated for 
10minutes in the dark. Results are presented as mean ± SEM. Significance was a one-way ANOVA 
and is indicated from the 0 hour oxLDL control. Significance levels are indicated as: (*) p  0.05, (**) 
p  0.01 and (***) p  0.001. 
 
 
3.5.3 The effect of 7,8-NP on U937 cells mitochondria membrane 
potential 
It is currently unknown what causes the significant reduction in mitochondrial 
potential when U937 cells are exposed to oxLDL. It is hypothesized that there is a 
link between the oxLDL induced oxidative stress mechanism and reduction in 
membrane potential. This was investigated by preincubating U937 cells with 0 - 
200µM 7,8-NP and exposed the U937 cells to oxLDL (0.20mg/mL) for 6 hours to 
determine if the 7,8-NP would prevent the reduction of the membrane potential. The 
results (Figure 3.5.5A) showed the oxLDL only treatment (0µM 7,8-NP) exhibited a 
significant 25% depolarization of membrane potential compared to the cell only 
control. Treatments with 100 & 200µM 7,8-NP + oxLDL exhibited a significant 25% 
reduction in membrane potential after 6 hours incubation compared to the cell only 
control. However, there was no significant difference between the oxLDL only or any 
of the 7,8-NP treatments, suggesting that 100 – 200µM 7,8-NP had no effect on the 
oxLDL induced membrane depolarization. The 200µM 7,8-NP only control had a 
significantly higher membrane potential than the cell only control indicating that 7,8-
NP is scavenging the basal level of mitochondria oxidative stress. However, when 
oxLDL is introduced there is no restorative effect occurring to the membrane 
potential suggesting that the mitochondria depolarization is not an oxidative stress 
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Figure 3.5.5 The mitochondrial membrane potential in U937 cells when exposed 
to low oxLDL concentration and increasing concentrations of 7,8-NP at 6 hours. 
U937 cells (500,000 cells/mL) were incubated with 0.20mg/mL oxLDL and varying concentrations of 
7,8NP (100 and 200µM) for 6 hours. Cells were washed and incubated with 100µM JC-1 for 20 
minutes. A) Results are presented as a ratio of Red:Green fluorescence and in triplicate ±SEM. 
Significance was a one-way ANOVA and is indicated from the 0 hour oxLDL exposed control. 
Significance levels are indicated as: (*) p  0.05, (**) p  0.01 and (***) p  0.001. B) Represents the 
dot plots of 10,000 individual gated cells treated with JC-1. 














































The effect of a higher oxLDL concentration was investigated when U937 cells were 
treated with increasing concentrations of 7,8-NP. U937 cells were treated with 
0.50mg/mL oxLDL for 6 hours with 0, 50, 100, 150 and 200µM 7,8-NP to determine 
if the higher oxLDL concentration would induce a greater mitochondrial 
depolarization that was not observed in Figure 3.5.5A and determine if increasing 
concentrations of 7,8-NP would mitigate the oxLDL-induced depolarization. The 
results showed that 0.50mg/mL oxLDL produced a significant 74% decrease in 
membrane potential in the oxLDL only treatment compared to the cell only control. 
All 7,8-NP treatments (50, 100, 150 and 200µM) and oxLDL showed a significant 
70% decrease in membrane potential compared to the cell only control, regardless of 
the 7,8-NP concentration (Figure 3.5.6A). This suggests that the decrease in 
mitochondrial membrane potential is not due to oxidative stress but infact could be a 
result of the cell undergoing a cell death. This idea is backed up in Figure 3.5.7 as it 
represents the cell viability from the same experiment. The results showed that there 
was a 50% decrease of PI negative cells after 6 hour oxLDL exposure, representing 
significant cell death in all of the oxLDL treatments, regardless of increasing 
concentrations of 7,8-NP. There was no statistical difference between the oxLDL only 
treatment and increasing concentrations of 7,8-NP. However, 7,8-NP did not protect 
against oxLDL induced cell death as shown earlier in Figure 3.1.2 at LD50 oxLDL 
concentration. This suggests that higher oxLDL concentration induces considerable 
damage to the cell, resulting in a significant reduction in membrane potential and 


















































Figure 3.5.6 The mitochondrial membrane potential in U937 cells when exposed 
to high oxLDL concentration and increasing concentrations of 7,8-NP at 6 hours. 
U937 cells (1,000,000 cells/mL) were incubated with 0.50mg/mL oxLDL and varying concentrations 
of 7,8NP (0, 50, 100, 150 and 200µM) for 6 hours. Cells were washed and incubated with 100µM JC-1 
for 20 minutes. Results were analyzed by Flow Cytometer using the FL1,FL2 filter. A) Results are 
presented as a ratio of Red:Green fluorescence and in triplicate ±SEM. Significance was a one-way 
ANOVA and is indicated from the 0 hour oxLDL exposed control. Significance levels are indicated as: 
(*) p  0.05, (**) p  0.01 and (***) p  0.001. B) Represents the dot plots of 10,000 individual gated 
cells treated with JC-1. 
 
 














































































Figure 3.5.7 The cell viability of U937 cells when exposed to high oxLDL 
concentration and increasing concentrations of 7,8-NP for 6 hours. 
U937 cells (1,000,000 cells/mL) were incubated with 0.50mg/mL oxLDL and varying concentrations 
of 7,8-NP (0, 50, 100, 150 and 200µM) for 6 hours. Cell viability was measured by PI and the data was 
expressed as a percentage of the control with no oxLDL. The different treatments were aliquoted into 
centrifuge tube and PI stain was added and incubated for 10minutes in the dark. Results were analyzed 
by Flow Cytometry under the FL-3 filter. Results are presented as mean ± SEM. Significance was a 
one-way ANOVA and is indicated from the respective control (0 µM 7,8-NP). Significance levels are 




The JC-1 dot plots (Figures 3.5.1B, 3.5.2B, 3.5.3B, 3.5.5B and 3.5.6B) all express 
the similar trend of an increase in FL1 fluorescence in the oxLDL treatments, with no 
subsequent decrease of FL2 fluorescence. The cell only control exhibits a high FL2 
with a low FL1 and contrasting to the opposite end of the spectrum, the CCCP control 
displays a low FL2 fluorescence and a high FL1 fluorescence. It was expected that 
both the dot plots and the FL2:FL1 ratio would display similar trends however, the 
JC-1 dot plot oxLDL treatments do not display the intermediate transition between 
these two extremes and only display an increase of FL1 fluorescence with no decrease 
in FL2. This is not in concert when the same data is displayed as a ratio of FL2:FL1 
(Figures 3.5.1A, 3.5.2A, 3.5.3A, 3.5.5A and 3.5.6A), which effectively displays the 
transition between the positive and negative control. 
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Myeloperoxidase (MPO) is a peroxidase enzyme that is secreted by activated 
neutrophils in conjunction with hydrogen peroxide (generated indirectly from NOX 
complex) for antimicrobial activity. Along with NOX-2 and the mitochondria, MPO 
is considered to be a contributing component in the oxidant generation that is 
involved in atherosclerosis (Hazen 1997, Madamanchi 2005). HOCl has also been 
shown previously in our lab to oxidize 7,8-NP to neopterin (Widner 2000, Parker 
2015). This section investigates the role of MPO inhibitors (thiocyanate ions and 4-
amino benzoic acid) on the cell viability of U937 cells when exposed to oxLDL. 
Further research investigates the contribution MPO has to the cytosolic oxidative 
stress using DHE staining. 
 
3.6.1 The effect of thiocyanate ions on the cell viability of U937 cells 
Preliminary experiments investigated the cytotoxicity of thiocyanate ions (NaSCN) on 
U937 cells. The cells were incubated with 0 - 600µM NaSCN for 24 hours to 
determine if the concentration range caused any cell death before the addition of 
oxLDL. The results show that there was a slight increase in PI negative cells at 400 - 
600µM NaSCN by 10%, although this was non-significant (Figure 3.6.1). There were 
no changes in the PI positive cells suggesting that the cells were unharmed. 
 
Further research investigated the antioxidant properties of SCN ions when incubated 
with oxLDL. U937 cells were incubated with 200 - 600µM NaSCN for 15 minutes 
before the incubation with 0.30mg/mL oxLDL for 24 hours. The results showed that 
there was a 40% decrease in the oxLDL treatment’s PI negative cells compared to the 
cell only control. Furthermore, there was no significant difference in the PI negative 
cells of the oxLDL only treatment and the NaSCN treatment at any concentration 
(Figure 3.6.2). This suggests that NaSCN is not having a protective effect on U937 



















Figure 3.6.1 The effect of increasing concentrations of NaSCN on cell viability 
U937 cells (0.5x10
6
 cells/mL) were treated with increasing concentrations of NaSCN for 24 hours in 
non-phenol red RPMI-1640. Cell viability was measured by PI and the data was expressed as a 
percentage of the cell only control. The different treatments were aliquoted into centrifuge tube and PI 
stain was added and incubated for 10minutes in the dark. Results were analyzed by Flow Cytometry 
under the FL-3 filter. Significance was a two way ANOVA and is indicated from the cell only control, 



















Figure 3.6.2 The effect of increasing concentrations of NaSCN on cells that have 
been exposed to 0.30mg/mL oxLDL. 
U937 cells (0.5x10
6
 cells/mL) were treated with increasing concentrations of NaSCN and 0.30mg/mL 
oxLDL for 24 hours in non-phenol red RPMI-1640. Cell viability was measured by PI and the data was 
expressed as a percentage of the control with no oxLDL. The different treatments were aliquoted into 
centrifuge tube and PI stain was added and incubated for 10minutes in the dark. Results were analyzed 
by Flow Cytometry under the FL-3 filter. Significance was a two way ANOVA and is indicated from 
the oxLDL (0µM SCN) control. Significance levels are indicated as: (*) p  0.05, (**) p  0.01 and 
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3.6.2 The effect of ABAH on the cell viability of U937 cells 
The possible role of MPO was further examined using MPO inhibitor, 4-amino 
benzoic acid (ABAH), on the oxLDL induced cell death. U937 cells were incubated 
with increasing concentrations of ABAH for 24 hours to determine if there were any 
preliminary cytotoxic effects occurring to the cells. The results showed that there was 
no significant change in PI negative cells when exposed to 0 - 300µM ABAH (Figure 
3.6.3), indicating there is no cytotoxic effect at that concentration range with just 
ABAH. 
 
U937 cells were then incubated with 0 - 300µM with 0.20mg/mL oxLDL for 24 hours 
to determine if there were any protective effects occurring to the PI negative cells. 
The results showed that there was a 5% increase in PI negative cells treated with 5 
and 100µM ABAH with oxLDL compared to the other treatments (Figure 3.6.3). 
























 cells/mL) were treated with increasing concentrations of ABAH and 0.20mg/mL 
oxLDL for 24 hours in non-phenol red RPMI-1640. Cell viability was measured by PI and the data was 
expressed as a percentage of the control with no oxLDL. The different treatments were aliquoted into 
centrifuge tube and PI stain was added and incubated for 10minutes in the dark. Results were analyzed 
by Flow Cytometry under the FL-3 filter. Significance was a two way ANOVA and is indicated from 
the oxLDL (0µM ABAH) control. Significance levels are indicated as: (*) p  0.05, (**) p  0.01 and 
(***) p  0.001. 
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3.6.3 The effect of ABAH on the cytosol intracellular oxidative stress 
Further research investigated the contribution MPO/hypochlorite had to the cytosol 
intracellular oxidative stress generated when U937 cells are incubated with oxLDL.  
Research by this laboratory has seen an increase in DHE staining when U937 cells are 
incubated with oxLDL (Katouah 2015); however, it is unknown if hypochlorite 
contributes to the oxidative stress. Preincubating U937 cells with ABAH would 
establish whether superoxide or hypochlorite is the major oxidant that is causing the 
oxidative stress when U937 cells are exposed to oxLDL. The results (Figure 3.6.4) 
showed that U937 cells that are incubated with oxLDL for 6 hours, there is a 60% 
significant increase in mean cellular fluorescence compared to the cell only control. 
However, there is no significant difference between the oxLDL control (0µM ABAH) 
or 5 - 300µM ABAH plus oxLDL treatments suggesting that hypochlorite does not 
contribute towards the DHE staining present within U937 cells. There was a decrease 
in mean cellular fluorescence at the 25µM ABAH with oxLDL treatment, although, 
this was not a significant decrease. The results indicate that the intracellular DHE 
staining is likely to be superoxide anions and hypochlorite is unlikely to be 















Figure 3.6.4 The effect of increasing concentrations of ABAH on the intracellular 
oxidative stress produced by oxLDL. 
U937 cells (0.5x10
6
 cells/mL) were treated with increasing concentrations of ABAH and 0.30mg/mL 
oxLDL for 6 hours in non-phenol red RPMI-1640. The cells were washed and incubated with 10µM 
DHE for 20minutes in the dark to measure the intracellular superoxide production from oxLDL. The 
cells were measured by Flow Cytometry under the FL2 filter. The data was expressed as a percentage 
increase of the 0 hour control and significance is relative to the 0-hour control. Significance was a one 
way ANOVA and is indicated from the oxLDL (0µM ABAH) control. Significance levels are indicated 
as: (*) p  0.05, (**) p  0.01 and (***) p  0.001. 




























































3.7 Cultured Plaque sections 
Live plaque tissue was excised from patients undergoing an endarterectomy surgery 
and sections were cultured for 96 hours to measure the change in neopterin, total 
neopterin, 7,8-dihydroneopterin and lactate output in to the media. Analysis of the 
plaque media was conducted through HPLC, measuring the neopterin and total 
neopterin of each samples in duplicate (section 2.2.9). The 7,8-NP was calculated 
through the subtraction of neopterin from total neopterin and lactate was measured 
through an assay kit from Roche diagnostics (section 2.2.8).  
 
3.7.1 The effect of sub-lethal oxLDL on cultured plaque sections 
The effect of oxLDL has been extensively studied in cell culture research, however, 
little is known what effect it has in physiological conditions. OxLDL was added to 
plaque tissue sections to determine if there were significant changes in the neopterin 
or 7,8-NP production. Every 24 hours fresh media was added to the sections along 
with a sub lethal concentration of oxLDL (0.25mg/mL) for a total of 72 hours. The 
samples were stored at -80C before analysis of neopterin, total neopterin and lactate 
of each sample. Analysis of the neopterin (Figure 3.7.1) over the 0 - 72 hours 
revealed a significant increase in sections 5 and 6 after 72 hours, with a significant 
increase of neopterin production in sections 1 and 7 at 48 hours and a subsequent 
decrease at 72 hours. Section 8’s 0-hour treatment displayed a significant production 
of neopterin however, this decreased significantly once oxLDL was added at 24hours. 
Total neopterin (Figure 3.7.2) produced by the oxLDL treated plaque had no 
significant change of total neopterin in all plaque sections between 0 – 72 hours 
oxLDL incubation. This indicates that sub-cytotoxic levels of oxLDL has no 
inflammatory effect within the plaque that lead to macrophage activation and up 
regulation of 7,8-NP production. This was confirmed by the 7,8-NP graph (Figure 
3.7.3) as the levels of 7,8-NP remained constant in sections 1-7 throughout the 72 
hour oxLDL incubation. This was an exception for section 8 with 7,8-NP production 
significantly increased at 24 hours. The lactate measurement (Figure 3.7.4) indicates 
that in all of the sections, there was no significant decrease in lactate production 
indicating that the cells metabolism are still intact, suggesting that the oxLDL 
concentration was non-toxic as expected. The lactate production in sections 1-7 




the plaque is becoming more glycolytic in response to the non-toxic concentration of 
oxLDL. Therefore the results indicate there is no immune activation or up-regulation 
of 7,8-NP production and a significant increase in plaque metabolism in the first 24 
hours when incubated with oxLDL. Interestingly, there was a significant increase in 

















































Figure 3.7.1 The effect of oxLDL on Plaque 113 neopterin production. 
Plaque 113 was sliced into 8 sections and incubated at 37ºC with RPMI 1640 with phenol red, 10% 
human serum, penstrep and 0.25mg/mL oxLDL. After 24, 48, 72 and 96 hours the media was collected 
and analyzed for neopterin through the HPLC. Two way ANOVA significance is indicated from the 0 
hour media control. The data is in duplicate from a single experiment. Significance levels are indicated 





















Figure 3.7.2 The effect of oxLDL on Plaque 113 total neopterin production. 
Plaque 113 was sliced into 8 sections and incubated at 37ºC with RPMI 1640 with phenol red, 10% 
human serum, penstrep and 0.25mg/mL oxLDL. After 24, 48,72 and 96 hours the media was collected 
and analyzed for neopterin through the HPLC. Data is presented in duplicate. Two way ANOVA 
significance is indicated from the 0 hour media control. The data is in duplicate from a single 
experiment. Significance levels are indicated as: (*) p  0.05, (**) p  0.01 and (***) p  0.001. 
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Figure 3.7.3 The effect of oxLDL on Plaque 113 7,8-dihydroneopterin 
production. 
Data represents the difference between neopterin and total neopterin values Data is presented in 
duplicate. Two way ANOVA significance is indicated from the 0 hour media control. The data is in 
duplicate from a single experiment. Significance levels are indicated as: (*) p  0.05, (**) p  0.01 and 





















Figure 3.7.4 The effect of oxLDL on Plaque 113 lactate production. 
Plaque 113 was sliced into 8 sections and incubated at 37ºC with RPMI 1640 with phenol red, 10% 
human serum, penstrep and 0.25mg/mL oxLDL. After 24, 48,72 and 96 hours the media was collected 
and stored at -80ºC before being analyzed on the Roche Diagnostics Lactate determination assay. Two 
way ANOVA significance is indicated from the 0 hour media control. The data is in duplicate from a 
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3.7.2 The effect of γ-interferon on cultured plaque sections 
γ-Interferon is an inflammatory cytokine that is important in the activation of 
macrophages to respond against viral and bacterial infections (Schoenborn 2007). γ-
Interferon (500units per mL) was added to the plaque culture to stimulate the immune 
cells within the plaque and to determine the magnitude of immune activation over the 
72-hour period. Stimulated macrophages release 7,8-NP, however, subsequent 
oxidation will form it’s oxidative product, neopterin, which can be utilized as a 
biomarker to quantify the oxidative stress within the plaque (Schumacher 1997, Fuchs 
2009). Total neopterin was measured to determine the 7,8-NP output from 
macrophage activation. 
 
Analysis of the neopterin (Figure 3.7.5) over 0 – 72 hours revealed a significant 
increase of neopterin production in plaque sections 1 – 7 compared to 0 hours starting 
point. This showed that a single dose of γ-interferon amplifies the inflammatory 
response after every 24 hours and stimulates the macrophages to release oxidants into 
the environment. Total neopterin (Figure 3.7.6) showed a significant increase in all of 
the time points compared to 0 hour γ-interferon exposure, except for section 1 where 
the 48 and 72 hour exposure plateaued. The 7,8-NP graph (Figure 3.7.7) showed in 
sections 1 – 4 there was a significant increase in 7,8-NP between 0 – 48 hours 
although a decline in 7,8-NP production at 72 hours. This indicates that oxidative 
stress is occurring in sections 1-4 at 48 -72 hours, depleting the levels of 7,8-NP. 
There was a gradual increase of 7,8-NP in sections 5-7 over the 72 hours except for 
48 hour with a reduction in 7,8-NP production.  
 
Lactate production (Figure 3.7.8) in sections 1-7, shows that there was no significant 
difference over the 72 hours, indicating that each plaque section is maintaining a 
stable metabolism and γ-interferon is not cytotoxic to the plaque sections.  
The data shows the decay of a single treatment of γ-interferon at 24 hours 
significantly increases oxidative stress and the 7,8-NP production of the plaque 
sections for 48 hours. The oxidative burst resulted in the oxidation of 7,8-NP and 























Figure 3.7.5 The effect of γ-Interferon on Plaque 112 neopterin production. 
Plaque 112 was sliced into 7 sections and incubated at 37ºC with RPMI 1640 with phenol red, 10% 
human serum and penstrep. After 24 hours, γ-interferon (500 units per mL) then subsequent media 
changes at 48, 72 and 96 hours. The media was collected and analyzed for neopterin through the 
HPLC. Two way ANOVA significance is indicated from the 0 hour media control. The data is in 
duplicate from a single experiment. Significance levels are indicated as: (*) p  0.05, (**) p  0.01 and 




















Figure 3.7.6 The effect of γ-Interferon on Plaque 112 total neopterin production. 
Plaque 112 was sliced into 7 sections and incubated at 37ºC with RPMI 1640 with phenol red, 10% 
human serum and penstrep. After 24 hours, γ-interferon (500 units per mL) then subsequent media 
changes at 48, 72 and 96 hours. The media was collected and analyzed for neopterin through the 
HPLC. Two way ANOVA significance is indicated from the 0 hour media control. The data is in 
duplicate from a single experiment. Significance levels are indicated as: (*) p  0.05, (**) p  0.01 and 
(***) p  0.001. Sample collection and analysis was in conjunction with Hannah Prebble. 
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Figure 3.7.7 The effect of γ-interferon on Plaque 112 7,8-dihydroneopterin 
production. 
Data represents the difference between neopterin and total neopterin values. Two way ANOVA 























Figure 3.7.8 The effect of γ-interferon on Plaque 112 lactate production. 
Plaque 112 was sliced into 7 sections and incubated at 37ºC with RPMI 1640 with phenol red, 10% 
human serum, penstrep. After 24 hours, γ-interferon (500 units per mL) then subsequent media changes 
at 48, 72 and 96 hours. The media was collected and stored at -80ºC before being analyzed on the 
Roche Diagnostics Lactate determination assay. Two way ANOVA significance is indicated from the 0 
hour media control. The data is in duplicate from a single experiment. Significance levels are indicated 
as: (*) p  0.05, (**) p  0.01 and (***) p  0.001. Sample collection and analysis was in conjunction 
with Hannah Prebble. 
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3.7.3 The effect of PMA on cultured plaque sections 
Phorbol myristate acetate (PMA) has been shown to directly stimulate protein kinase 
C that in turn activates the NOX complex by phosphorylation of p47
phox
. Activation 
of NOX induces extracellular release of oxidants, causing an oxidative stress 
environment (Karlsson 2000). Cultured live plaque sections were treated with 5µM 
PMA to stimulate T-cell activation in the plaque which is in turn was thought to 
stimulate the production of 7,8-NP. The activation of NOX has been reported to 
induce the release of oxygen radicals which react with 7,8-NP, forming it’s oxidative 
product, neopterin.  
The effect of PMA on plaque sections was investigated through analysis of lactate 
(Figure 3.7.12), neopterin (Figure 3.7.9) and 7,8-NP production (Figure 3.7.10 & 
3.7.11) over 72 hours. The plaque was incubated in RPMI -1640 with 10% human 
serum media for 24 hours to determine the baseline of 7,8-NP and neopterin 
production. PMA was added to the plaque media after 24 (PMA day 1) and 48 (PMA 
day 2). Analysis of the neopterin (Figure 3.7.9) over 0-72 hours revealed a significant 
increase in neopterin production in all of the plaque sections except 4 and 5. There 
was a significant increase in neopterin production at PMA day 1 in all of the sections 
except 4 and 5 compared to the media only control. There was another significant 
increase in neopterin production in all of the plaque sections except 4 and 5 at PMA 
day 2, suggesting second day of PMA exposure the plaque has the biggest response to 
PMA. Total neopterin (Figure 3.7.10) showed a significant increase in all of the 
sections except 5 and 8 over the PMA exposure. This suggests that the plaque sections 
are up regulating the 7,8-NP production in response to PMA exposure. This was 
confirmed in Figure 3.7.11 as there was a significant increase in 7,8-NP production in 
sections 1-3 compared to the media control. In sections 4-8 there was still a slight 
increase in 7,8-NP production suggesting this is occurring throughout the plaque 
sections. 
The lactate graph (Figure 3.7.12) shows a significant increase in lactate production at 
PMA day 1 and 2 in sections 2-3, 6-8. This indicates that the PMA is increasing the 
plaque metabolism in both PMA days 1 & 2 which is shown by an increase in lactate 
production, however in section 1, there is a significant decrease in lactate production 














Figure 3.7.9 The effect of 5µM PMA on Plaque 120 neopterin production. 
Plaque 120 was sliced into 8 sections and incubated at 37ºC with RPMI 1640 with phenol red, 10% 
human serum and penstrep. After 0, 24, 48, and 72 hours the media was collected and analyzed for 
neopterin through the HPLC. Two way ANOVA significance is indicated from the 0 hour media 
control. The data is in duplicate from a single experiment. Significance levels are indicated as: (*) p  















Figure 3.7.10 The effect of 5µM PMA on Plaque 120 total neopterin production. 
Plaque 120 was sliced into 8 sections and incubated at 37ºC with RPMI 1640 with phenol red, 10% 
human serum and penstrep. After 24, 48,72 and 96 hours the media was collected and analyzed for 
neopterin through the HPLC. Two way ANOVA significance is indicated from the 0 hour media 
control. The data is in duplicate from a single experiment. Significance levels are indicated as: (*) p  
0.05, (**) p  0.01 and (***) p  0.001. 
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Figure 3.7.11 The effect of 5µM PMA on Plaque 120 7,8-dihydroneopterin 
production. 
Data represents the difference between neopterin and total neopterin values. Two way ANOVA 
significance is indicated from the 0 hour media control. The data is in duplicate from a single 












Figure 3.7.12 The effect of 5µM PMA on Plaque 120 lactate production. 
Plaque 120 was sliced into 8 sections and incubated at 37ºC with RPMI 1640 with phenol red, 10% 
human serum, penstrep. After 24, 48,72 and 96 hours the media was collected and stored at -80ºC 
before being analyzed on the Roche Diagnostics Lactate determination assay. Two way ANOVA 
significance is indicated from the 0 hour media control. The data is in duplicate from a single 
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3.7.4 The effect of PMA and apocynin on cultured plaque section 
As explained in Section 1.7.2, apocynin is a non-specific NOX inhibitor and 
functions by preventing the assembly of NADPH oxidase (NOX). The plaque was 
incubated in RPMI -1640 with 10% human serum media for 24 hours to determine the 
baseline of 7,8-NP and neopterin production. PMA was added to the plaque media 
after 24 hours to increase the oxidative stress within the plaque and PMA + apocynin 
was added after 48 hours to determine the effect the apocynin had on the neopterin 
production. 
Analysis of the neopterin (Figure 3.7.13) showed a significant increase in neopterin 
production compared to the media control when incubated with 5µM PMA, similar to 
what was observed in Figure 3.7.9. A second incubation with 5µM PMA and 20µM 
apocynin showed a plateau or reduction of neopterin production in plaque sections 1-
4. The plateau suggests that the apocynin reduced the NOX activity, minimizing the 
number of oxidants available to react with 7,8-NP. Section 4 showed a significant 
decrease in neopterin when apocynin was added; however, plaque section 8 showed a 
continuous increase over the duration. Interestingly, the total neopterin (Figure 
3.7.14) showed a significant increase in all of the sections after the incubation with 
both PMA + apocynin, contrasting Figure 3.7.13 where total neopterin plateau when 
apocynin was added. This suggests that apocynin is likely to have inhibited the NOX 
activity, preventing the production of oxidants and subsequent oxidation of 7,8-NP. 
This view was supported by the 7,8-NP graph (Figure 3.7.15), showing a significant 
burst of 7,8-NP production in all sections except 8 when apocynin + PMA was added 
compared to PMA only treatment. This suggests that the apocynin is inhibiting 
oxidant production and leaving excess 7,8-NP within the plaque.  
The lactate graph (Figure 3.7.16) indicates the cell metabolism when exposed to 
PMA or apocynin. Sections 1 and 3 show a dramatic increase in metabolism once the 
PMA has been added. Results show a significant crash in lactate production once the 
PMA + apocynin has been added. Sections 2 and 4-8 show a gradual decrease in 
metabolism media only. This suggests that the PMA is changing the cellular 
metabolism or apocynin is causing the cell to undergo redox stress as apocynin has 
been shown to significantly increase intracellular glutathione concentrations, causing 
damage to the cell. However, the cell is still producing large amounts of 7,8-NP 





Therefore the results indicate that treatment of apocynin significantly decreased the 
oxidative stress produced by PMA and prevented the oxidation of 7,8-NP. Production 
of 7,8-NP suggests that the plaque is alive and functioning, although this conflicts 
with the lactate data that suggests that the plaques metabolism has significantly 

















































Figure 3.7.13 The effect of PMA and apocynin on Plaque 114 neopterin 
production. 
Plaque 114 was sliced into 8 sections and incubated at 37ºC with RPMI 1640 with phenol red, 10% 
human serum and penstrep. After 0, 24, 48, and 72 hours the media was collected and analyzed for 
neopterin through the HPLC. Two way ANOVA significance is indicated from the 0 hour media 
control. The data is in duplicate from a single experiment. Significance levels are indicated as: (*) p  




















Figure 3.7.14 The effect of PMA and apocynin on Plaque 114 total neopterin 
production. 
Plaque 114 was sliced into 8 sections and incubated at 37ºC with RPMI 1640 with phenol red, 10% 
human serum and penstrep. After 24, 48,72 and 96 hours the media was collected and analyzed for 
neopterin through the HPLC. Two way ANOVA significance is indicated from the 0 hour media 
control. The data is in duplicate from a single experiment. Significance levels are indicated as: (*) p  
0.05, (**) p  0.01 and (***) p  0.001. 
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Figure 3.7.15 The effect of PMA & apocynin on Plaque 114 7,8-dihydroneopterin 
production. 
Data represents the difference between neopterin and total neopterin values. Two way ANOVA 
significance is indicated from the 0 hour media control. The data is in duplicate from a single 























Figure 3.7.16 The effect of PMA & apocynin on Plaque 114 lactate production. 
Plaque 114 was sliced into 8 sections and incubated at 37ºC with RPMI 1640 with phenol red, 10% 
human serum, penstrep. After 24, 48,72 and 96 hours the media was collected and stored at -80ºC 
before being analyzed on the Roche Diagnostics Lactate determination assay. Two way ANOVA 
significance is indicated from the 0 hour media control. The data is in duplicate from a single 
experiment. Significance levels are indicated as: (*) p  0.05, (**) p  0.01 and (***) p  0.001. 
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3.7.5 The effect of PMA and gp91ds-tat on cultured plaque sections 
Gp91ds-tat is a peptide that is designed to inhibit the assembly of the NOX complex, 
reducing the extracellular superoxide production. This experiment was a follow-up 
from the PMA + apocynin research that targets the NOX complex to reduce the 
oxidation of 7,8-NP to its highly fluorescent product, neopterin. 
Apocynin and gp91ds-tat have similar mechanisms of inhibiting the assembly and 
activation of NOX complex. Therefore, similar trends were expected to have been 
seen such as a plateau effect occurring to the neopterin production as seen in Figure 
3.7.13 and increasing 7,8-NP after each media change as seen in Figure 3.7.15 due to 
T-cell activation from PMA. 
The plaque was incubated in RPMI-1640 with 10% human serum media for 24 hours 
to determine the baseline of 7,8-NP and neopterin production. PMA was added to the 
plaque media after 24 hours to increase the production of oxidative stress within the 
plaque and PMA plus gp91ds-tat was added after 48 hours to determine the effect the 
peptide inhibitor had on the neopterin production when NOX activity was 
significantly reduced. 
Analysis of the neopterin (Figure 3.7.17) showed a significant increase in neopterin 
production compared to the media control when incubated with 5µM PMA, similar to 
what was observed in Figure 3.7.9. However, second incubation with 5µM PMA and 
0.5µM gp91ds-tat showed an significant increase in neopterin production in plaque 
sections 1-7. This suggests that the gp91ds-tat was not inhibiting the NOX complex or 
preventing the oxidation of 7,8-NP. Total neopterin (Figure 3.7.18) showed a 
significant increase in sections 1-7 after the 48 hours incubation with both PMA plus 
gp91ds-tat. The 7,8-NP concentrations (Figure 3.7.19) were significantly increased in 
sections 1 – 7 after gp91ds-tat + PMA exposure compared to PMA only treatment.  
The lactate (Figure 3.7.20) showed an increase in lactate production in sections 1-7 
when PMA added but a decrease in lactate production occurred with PMA plus 
gp91ds-tat treatment. These results are similar findings to what was observed in the 
initial PMA only study (Figures 3.7.9 - 12) suggesting that there is no inhibitory 
effect occurring when 0.5µM gp91ds-tat was added to the plaque media. Future 
research could investigate higher concentrations (1µM) of the inhibitor to see if there 



















Figure 3.7.17 The effect of 5µM PMA and 0.5µM gp91ds-tat on Plaque 116 
neopterin production. 
Plaque 116 was sliced into 7 sections and incubated at 37ºC with RPMI 1640 with phenol red, 10% 
human serum and penstrep. After 24, 48, 72 and 96 hours the media was collected and analyzed for 
neopterin through the HPLC. Two way ANOVA significance is indicated from the 0 hour media 
control. The data is in duplicate from a single experiment. Significance levels are indicated as: (*) p  



















Figure 3.7.18 The effect of 5µM PMA and 0.5µM gp91ds-tat on Plaque 116 total 
neopterin production. 
Plaque 116 was sliced into 7 sections and incubated at 37ºC with RPMI 1640 with phenol red, 10% 
human serum and penstrep. After 24, 48, 72 and 96 hours the media was collected and analyzed for 
total neopterin through the HPLC. Two way ANOVA significance is indicated from the 0 hour media 
control. The data is in duplicate from a single experiment. Significance levels are indicated as: (*) p  
0.05, (**) p  0.01 and (***) p  0.001. 
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Figure 3.7.19 The effect of gp91ds-tat on Plaque 116 7,8-dihydroneopterin 
production. 
Data represents the difference between neopterin and total neopterin values. Two way ANOVA 
significance is indicated from the 0 hour media control. The data is in duplicate from a single 




















Figure 3.7.20 The effect of 5µM PMA and 0.5µM gp91ds-tat on Plaque 116 
lactate production. 
Plaque 116 was sliced into 7 sections and incubated at 37ºC with RPMI 1640 with phenol red, 10% 
human serum, penstrep and 0.25mg/mL oxLDL. After 24, 48,72 and 96 hours the media was collected 
and stored at -80ºC before being analyzed on the Roche Diagnostics Lactate determination assay. Two 
way ANOVA significance is indicated from the 0 hour media control. The data is in duplicate from a 
single experiment. Significance levels are indicated as: (*) p  0.05, (**) p  0.01 and (***) p  0.001. 
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Previous studies have shown that oxLDL toxicity is caused by an over production of 
intracellular oxidants indicated by an increase of cellular DHE staining (Figure 
3.3.1), loss of cellular glutathione (Kappler 2007, Gieseg 2010 B), reduction in 
essential metabolic enzyme activity (Katouah 2015) and loss of caspase function 
(Baird 2004, Gieseg 2008). Metabolic dysfunction and inactivation of caspase-3 
through the oxidative damage to the thiol groups result in the inability of the cell to 
undergo apoptosis and defaults to necrosis (Baird 2004, Katouah 2015). This study 
investigated the source of the cytotoxic oxidative stress triggered by the presence of 
oxLDL in U937 monocyte like cells. The research investigated whether NADPH 
oxidase, myeloperoxidase or uncoupled mitochondria generated intracellular oxidants 
in response to oxLDL. 
4.1  NADPH oxidase (NOX) & Oxidative stress 
4.1.1 NOX, a primary source of oxidative stress 
Chen (2012) investigated the role of NOX-2 in the intracellular superoxide generation 
in response to oxLDL and this study follows on from their previous research. This 
research explored the hypothesis of oxLDL inducing a hyper activation of the NOX 
complex and generating an overproduction of intracellular oxidants causing 
significant U937 cell death. 
 
This research utilized a highly specific peptide NOX inhibitor called gp91ds-tat that 
was designed by Rey (2001). This inhibitor specifically binds to P47phox subunit and 
prevents the assembly and activation of NOX. Gp91ds-tat showed a significant 
reduction of intracellular superoxide generation when U937 cells were incubated with 
oxLDL (Figure 3.4.3 and 3.4.5). The significant reduction of intracellular superoxide 
suggests that NOX is the major source of oxLDL-induced oxidative stress. This is in 
concert with what was observed in Rey (2001), as they showed that gp91ds-tat caused 
a 35% decrease of NOX activity in human neutrophils and an 80% reduction in 
superoxide production in a cell free assay. Other research utilising this inhibitor found 
it to be very effective causing an 80% reduction in superoxide production in bovine 




Rey (2001) states that gp91ds-tat is capable of inhibiting other NOX homologs that 
contain the gp91phox and P47phox subunits. However, there is little evidence in the 
literature of other NOX homologs present in phagocytic cell lines or research of 
gp91ds-tat concentration toxicity occurring in other cell lines (Bánfi 2001, Bánfi 
2003). 
 
It was expected that the reduction in superoxide generation would prevent oxidative 
damage occurring to the cell and a subsequent increase of cell viability. However, the 
inhibitor provided virtually no cell viability protection when U937 cells were 
incubated with oxLDL (Figure 3.4.4 and 3.4.6).  This laboratory has shown 
previously that apocynin reduced intracellular superoxide production in U937 cells, 
like gp91ds-tat, apocynin only provided a 20% protection against oxLDL induced cell 
death (Chen 2012). Apocynin has been shown to cause the cell to undergo reductive 
stress by inducing an up regulation of GSH production (Lapperre 1999). It is 
unknown if gp91ds-tat induces the same effect as GSH was not measured. 
 
The lack of cell viability protection could also be a result of chronic oxLDL exposure 
and the cell is already committed to cell death (Tabas 1997, Tabas 2010) or the 
residual oxidative stress is inducing significant oxidative damage to the cell. Gp91ds-
tat inhibited the intracellular oxidative stress by 70 – 90% (Figure 3.4.5 & 3.4.3) and 
there is a number of theories that could explain the residual 10 – 30% oxidative stress 
and the lack of cell viability. 
 
Dihydroethidium is a known fluorescent probe that reacts with intracellular 
superoxide and intercalates in the DNA, emitting a red fluorescence (Peshavariya 
2007). There is some conjecture on whether the probe is an accurate representation of 
oxLDL-induced oxidative stress or if the gp91ds-tat inhibition is a gross-exaggeration 
of the events that are occurring. It is unknown if the cells are exposed to more 
oxidative stress than what is being detected with DHE, potentially explaining the lack 
of cell viability protection. 
 
Another explanation is the possibility of a secondary source contributing to the 
residual oxidative stress. It is possible that oxLDL activates other NOX homologs and 




leukaemia and X-CGD CD34+ PBSC cells), Geiszt (2003) demonstrated that a 
complete NOX2 knockout showed an up regulation of other NOX homologs to 
compensate for the NOX-2 deficiency (Geiszt 2003). However, it is highly unlikely as 
complete NOX-2 inhibition in U937 cells would be unable to up regulate other NOX 
isoforms within 6 hours of oxLDL exposure.  
Additionally, it was demonstrated that NOX4 was inducible in human macrophages 
and monocytes treated with oxLDL (Lee 2010). Although, Othman (2015) 
demonstrated in U937 cells, that VAS2870 (NOX4 inhibitor) did not reduce the 
intracellular oxidative stress or provided no cell viability protection against oxLDL 
(Othman 2015). This suggests that NOX4 is not induced by oxLDL in the U937 cell 
oxidative stress mechanism. 
 
OxLDL could be inducing additional sources of intracellular oxidative stress (the 
mitochondria (Section 4.3.2), myeloperoxidase (Section 4.2) and xanthine oxidase), 
which may contribute to the production of intracellular oxidants. Xanthine oxidase 
catalyses the degradation of hypoxanthine and xanthine to uric acid and giving off 
superoxide as a byproduct (Schulze 2005). Xanthine oxidase activity has been 
reported to increase by 200% and closely associated with increased vascular oxidative 
stress in patients with chronic heart failure (Landmesser 2002). However, there is 
little evidence of oxLDL stimulating xanthine oxidase to produce oxidative stress in 
isolated macrophages.  
 
The most convincing explanation is that gp91ds-tat is a competitive inhibitor for the 
binding site on the P47phox subunit, inhibiting the activation of the NOX-2 complex. 
The inhibitor can reversibly bind to the binding site and is competing with the 
gp91phox subunit that activates the complex, generating superoxide (Rey 2001). 
This explains why at lower gp91ds-tat concentrations, there is less inhibitor 
competing for the p47phox-binding site, with the intracellular oxidative stress 
decreasing with increasing inhibitor concentration (Figure 3.4.5 & 3.4.3). However, 
even at maximum inhibitor concentrations, there was not 100% NOX inhibition 
because the gp91phox subunit was still competing for the binding site and activating 
complex, generating the residual oxidative stress. This provides insight that the 
oxidative mechanism is not as clear-cut as previously thought, as partial removal of 




cells are either committed to the oxLDL induced cell death as soon as 6 hours through 
ER stress (Tabas 2010, Tsukano 2010) or the residual oxidative stress is still causing 
extensive damage to the cell. 
 
An important question arising from this study is whether the increase of intracellular 
oxidative stress (Figure 3.3.1) was solely superoxide or a combination of 
hypochlorite and superoxide. Dihydroethidium fluorescent probe is supposed to react 
specifically with superoxide anions however, hypochlorite needed to be eliminated 
from the equation to ensure that the intracellular oxidative stress was entirely 
superoxide. A potent MPO inhibitor (ABAH) was utilized as a tool to inhibit the 
generation of hypochlorite (Kettle 1997), the experiment showed that the intracellular 
oxidative stress was specifically superoxide and not hypochlorite (Figure 3.6.4). This 
suggests that the intracellular oxidative stress generated in response to oxLDL 
exposure is superoxide (Katouah 2015). This is important as it supports the theory 
that oxLDL is inducing overproduction of superoxide generated from the NOX 
complex. 
4.1.2 NOX is causing the intracellular oxidation of 7,8-NP 
Neopterin has been extensively used as a clinical marker of immune cell activation in 
a variety of inflammatory diseases, including cardiovascular disease (Berdowska 
2001, Gieseg 2008). It is often stated that neopterin is the oxidative product of 7,8-
dihydroneopterin (Firth 2008, Mangge 2014), however, the mechanism of neopterin 
generation in cells is currently unknown. 7,8-Dihydroneopterin has been shown to 
have antioxidant capabilities, by providing cell viability protection (Figure 3.1.4) and 
causing a reduction of intracellular oxidative stress (Figure 3.3.2) in U937 cells. 
These results are in agreement with Gieseg (2010 B) as they saw 7,8-NP cell viability 
protection in HMDM. 
 
In vitro study 
Previous in vitro research has implicated NOX in the intracellular superoxide 
generation by treating oxLDL exposed U937 cells to apocynin. It was shown that 
apocynin significantly reduced the intracellular superoxide generation and restored 
the glutathione (Chen 2012). Additionally, it was demonstrated in peritoneal 




expression of atherogenic cytokines (Kinoshita 2013). NOX2 was further implicated 
in the oxLDL-induced mechanism as NOX-2 expression was equally elevated in 
oxLDL or PMA treated U937 cells, suggesting that oxLDL can activate the NOX2 
complex and generate oxidants (Katouah 2015). This sections objective was to 
investigate the involvement of NOX-2 in the oxidation of 7,8-NP to neopterin in 
oxLDL exposed U937 cells. It was shown that oxLDL induced a significant elevation 
of intracellular neopterin in U937 cells at 6 hours, corresponding to oxLDL-induced 
7,8-NP oxidation (Figure 3.3.7 – 3.3.9). Similar findings were found in a previous 
studies with HMDM, observing a significant generation of intracellular neopterin 
between 6 – 12 hours oxLDL exposure (Shchepetkina 2013). This suggests that 
oxLDL is inducing an increased production of intracellular oxidants that is oxidizing 
7,8-NP to neopterin. This research has suggested that NOX-2 is implicated in the 
acute oxLDL toxicity mechanism (Figure 3.4.3 & 3.4.5) along with superoxide 
anions (Figure 3.6.4). This led to the hypothesis that superoxide is causing the 
intracellular oxidation of 7,8-NP to neopterin in HMDM and U937 cells. U937 cells 
that were incubated with a potent NOX inhibitor (apocynin) showed a significant 
reduction of intracellular neopterin generation after 12 hours (Figure 3.3.10 – 3.3.11). 
Similar results were shown in our laboratory with HMDM, showing a significant 
reduction of neopterin production after 12 hour incubation with both oxLDL and 
apocynin compared to the oxLDL only treatment (Shchepetkina 2013). This suggests 
that NOX-2 plays an important role in the intracellular oxidation of 7,8-NP and 
confirming that superoxide is the major intracellular oxidant in both U937 cells and 
HMDM. A notable difference between this research and Shchepetkina (2013) (besides 
the different cell type) was the concentration of apocynin and the length of 
preincubation before the addition of oxLDL. HMDM were preincubated with 200µM 
apocynin for 3 hours before the addition of oxLDL and showed a significant reduction 
of intracellular neopterin at 6 hours (Shchepetkina 2013). When U937 cells were 
preincubated with 20µM apocynin for 15 minutes before the addition of oxLDL, there 
was a significant reduction of neopterin at 12 hours. Ignoring the differences between 
cell types, this indicates that apocynin requires a prolonged preincubation period to 






In vivo study 
Previous research in this lab has mainly focused on in vitro studies, utilizing cell lines 
to mimic the conditions of what macrophages would experience in an atherosclerotic 
plaque. The following research focused on culturing atherosclerotic plaques and 
comparing to what is being observed in vitro research. It is commonly accepted that 
NOX-2 plays an important role in the oxidative events that are occurring within the 
atherosclerotic plaque. Previous research has developed a clear link between 




) mice have elevated levels of NOX-2 
expression and through the deletion of NOX2, resulted in the inhibition of lesion 
development (Judkins 2010). Additionally, atherosclerotic lesions had significant 
superoxide staining accompanied with increased NOX2 expression (Sorescu 2002). 
These studies suggested that NOX2 has a more prominent role in atherosclerotic 
lesion development than expected. 
 
Like the in vitro research, this sections objective was to investigate the involvement 
of NOX-2 in the oxidation of 7,8-NP to neopterin in atherosclerotic plaque sections. 
PMA is an inflammatory cytokine that directly stimulates protein kinase C (PKC) 
which in turn induces the production of 7,8-NP and assembly of the NOX-2 complex 
in activated macrophages (Karlsson 2000). This research investigated the use of NOX 
inhibitors (apocynin and gp91ds-tat) to see if they prevented the oxidation of 7,8-NP 
in immune activated plaque sections. Apocynin treated plaque sections (Figure 3.7.13 
- 15) showed significant reduction in 7,8-NP oxidation and neopterin formation. 
These results were in agreement to what was observed in apocynin treated cell culture 
experiments (Figure 3.3.10 – 3.3.11) with a reduction of 7,8-NP oxidation through 
the inhibition of oxidants generated from the NOX-2 complex. This indicates that the 
apocynin has inhibited the oxidant production by blocking the activation of NOX that 
in turn prevents further oxidation of 7,8-NP. Gp91ds-tat activated plaque sections 
(Figure 3.7.17 - 19) did not prevent the 7,8-NP oxidation, suggesting that NOX-2 was 
not inhibited. We suspect that a higher concentration of gp91ds-tat was required to 
see similar results to what was found in the apocynin-treated plaque sections (Figure 








) mice treated 
with apocynin marked a significant reduction of atherosclerotic lesion size in thoracic 








 mice by inhibiting the generation of superoxide 
from the NOX complex (Kinkade 2013). Collectively, the data suggests that NOX-2 
is the primary source of oxidative stress in both oxLDL-exposed U937 cells and PMA 
activated plaque sections. Additionally, NOX-generated superoxide appears to be the 
major intracellular oxidant that is generated causing the extensive oxidative damage 
and subsequent cell death. OxLDL-induced cell death is a key player in the 
development of the necrotic core, driving the progression of the atherosclerotic 
plaque. 
4.2 Myeloperoxidase (MPO) 
 
Myeloperoxidase has been considered to be another potential source of oxidative 
damage to the cell and resulting in subsequent cell death. Sugiyama (2004) 
demonstrated that MPO-positive macrophages can disrupt the endothelial cell 
monolayer and induce cell death. The concentrations of hypochlorite that were 
reported in Sugiyama (2004) were within range of what is found in sites of 
inflammation (Epstein 1989). Hypochlorite has been shown to be a common 
substituent in atherosclerotic plaque, suggesting that MPO is highly active within this 
site (Hazen 1997). Hypochlorite can directly induce endothelial dysfunction (Zhang 
2001), degrade the extracellular matrix proteins between endothelial cells (Vissers 
1997), and activate dormant metalloproteinase which can make the atherosclerotic 
plaque unstable (Galis 1994, Fu 2001). In vitro research has shown hypochlorite to 
induce cell death by decreasing cellular ATP levels (Schraufstätter 1990) and rapidly 
provoke endothelial apoptosis, likely through GSH depletion, Bcl-2 degradation and 
cytochrome c release from the mitochondria (Sugiyama 2004). As MPO and its 
oxidative products have been extensively found within atherosclerotic lesions, this 
research investigated the link between oxLDL exposure and MPO induced oxidative 
stress in U937 cells. It was hypothesized that U937 cells incubated with MPO 
inhibitors (thiocyanate & ABAH) would prevent hypochlorite formation thus 
preventing oxidative damage occurring to the cell and restore the cell viability. U937 
cells incubated with thiocyanate (SCN) ions showed no protective effects occurring to 
the cell viability when exposed to oxLDL (Figure 3.6.2). Thiocyanate has been 
shown to provide protective effects in human lung epithelial cell line (Calu-3) against 




ABAH showed virtually no protection against oxLDL treatments (Figure 3.6.3), 
suggesting that MPO does not play a part in the oxLDL induced cell death 
mechanism. However, ABAH has been shown to provide significant cell viability 
protection against oxidant-generated apoptosis in myeloid leukaemia cells (HL-60, 
NB4 and UF-1). This was due to ABAH causing a significant reduction in MPO 
activity, oxidant production and a subsequent increase in cell viability (Nakazato, 
2007). Both ABAH and thiocyanate have been shown to be potent inhibitors against 
hypochlorite and hydrogen peroxide mediated cell death. In our experiments no 
protection against oxLDL induced cell death was observed with these inhibitors. This 
suggests that U937 cells are dying of the oxLDL-induced toxicity regardless of MPO 
inhibition, suggesting that MPO does not play a part in the in vitro oxLDL induced 
U937 cell death mechanism. An experiment performed by Kramarenko (2006) 
showed that U937 cells had undetectable MPO activity suggesting that U937 cells do 
not secrete activated MPO enzyme (Kramarenko 2006). This explains the lack of cell 
viability protection with MPO inhibitors because U937 cells have little MPO activity 
to begin with. 
 
4.3  Mitochondria induced oxidative stress 
Mitochondria produce a basal level of superoxide anions as a result of electron 
leakage from complex I and III (Lenaz 2002). It was considered that if the 
mitochondria had received significant damage that the reverse electron transport chain 
phenomenon would produce a large amount of oxidative stress within the cell (Liu 
2002). This suggested that the mitochondria could be a potential source of 
intracellular oxidative stress as significant oxLDL damage to U937 cells could 
produce oxidative stress. 
4.3.1 JC-1 assay provided inconclusive evidence 
Our research set out to investigate the effect oxLDL on the mitochondria, what time 
frame is this damage was occurring and whether 7,8-NP protected the mitochondria 
from the oxLDL-induced damage. We expected to determine the effect oxLDL had on 
the mitochondria and show that it was an oxidative stress damaging the mitochondria. 
The JC-1 staining technique functions by forming aggregates within the mitochondria 




mitochondria exhibit a high mitochondrial potential through red-aggregation of the 
dye, while the dye forms green monomers at low membrane potential. Mitochondria 
that exhibit a strong red fluorescence (FL-2) have a high mitochondrial potential 
whereas mitochondria that have a high green fluorescence (FL-1) have a low 
mitochondrial membrane potential (Galluzzi 2007, Honeychurch 2012). The results 
showed that oxLDL induced a significant depolarization of the mitochondria 
membrane potential at 6 hours (Figure 3.5.1& 3.5.2) and that 7,8-NP did not protect 
the mitochondria depolarization (Figure 3.5.5 & 3.5.6). However, the oxLDL 
treatment dot plots did not display the intermediate stages of what was shown in the 
cell only control (healthy mitochondria - high FL-2 and a low FL-1) and the CCCP 
control (unhealthy mitochondria - decrease in FL-2 with an increase in FL-1). The 
FL-2:FL-1 ratio graphs (Figure 3.5.1& 3.5.2) displayed a clear trend of a significant 
reduction of FL-2 with a proportional increase of FL-1 between the two controls (cell 
only and CCCP). As there was no consistency between these two data sets, we are 
unable to draw conclusions from these findings, as we believe there is a fundamental 
problem residing in the JC-1 assay. In comparison to research presenting JC-1 dot 
plots, sea urchin sperm cells showed a significant 89% decrease in the FL-2 dot plots 
compared to the healthy control, but did not see an increase of FL-1 green monomers 
(Binet 2014). Similar research examining the JC-1 dot plots of horse sperm cells, 
showed a decrease in FL-2 with an increase of FL-1 fluorescence (Gravance 2000). 
The dot plots from Gravance (2000) displayed similar trends to what was stated by 
the manufactures (decrease in FL-2 with a subsequent increase of FL-1 fluorescence 
for unhealthy mitochondria) that was not observed in this research or Binet (2014). 
Further research should utilize another mitochondria specific marker to assess the 
mitochondria membrane potential as a result of oxLDL exposure. 
4.3.2 The involvement of the mitochondria in oxidative stress 
The mitochondria is considered to be one of the major sources of oxidative stress in 
the cell, capable of generating superoxide anions, hydrogen peroxide, and hydroxyl 
radicals within the cell (Esposito 1999). Inhibition of the mitochondria electron 
transport chain by antimycin A (complex III inhibitor) results in a significant increase 
in mitochondrial superoxide (Boveris 1973, Boveris 1975) and hydrogen peroxide 
production (Kwong 1998, Chen 2003). This results in the phenomenon observed in 




anions. Significant oxidative damage to the mitochondria through oxLDL could result 
in the decoupling of mitochondrial ATP generation and increased oxidant production 
from the mitochondria. OxLDL-induced damage to the mitochondria could contribute 
to either increased intracellular oxidative stress or the cell undergoing a cell death as 
the mitochondria is known to have an essential role in an apoptotic programmed cell 
death (Murphy 2009). Previous research using MitoSOX dye in our laboratory 
suggested there was significant generation of mitochondrial superoxide within U937 
cells when incubated with increasing concentrations of oxLDL (Chen 2012). 
Comparison between the DHE staining and the mitochondrial superoxide production 
suggested that mitochondrial superoxide generation could be a secondary event 
initiated by excess cytoplasmic oxidative stress. This indicated that the mitochondria 
oxidant generation was a later event rather than a primary source (Chen 2012). 
Although the JC-1 mitochondrial data did not provide an accurate conclusion, 
previous research suggests that the mitochondria could contribute to the oxLDL-
induced intracellular oxidative stress through mitochondria dysfunction. As the 
mitochondria is involved in cell survival and death, extensive oxidative damage could 
cause cell death and eventuate to necrotic core development and disease progression. 
 
4.4 General discussion  
Atherosclerosis is a complex disease that is a caused by constant inflammation of the 
inner arterial intima due to death of macrophages as a result of oxLDL exposure 
(Libby 2002). Previous literature suggests that oxLDL induces its cytotoxicity 
through cholesterol accumulation and ER stress (Myoishi 2007, Tsukano 2010, Scull 
2011). However, from this research it can be hypothesized that oxLDL can induce 
two mechanisms, a rapid cytotoxicity (oxidative stress generation) and a chronic 
toxicity (ER stress). This research extensively studies the acute toxicity of oxLDL, 
inducing significant oxidant generation within U937 cells (Figure 3.3.1) and causing 
significant cell death (Figure 3.1.1). The hypothesized cytotoxicity mechanisms of 



















Figure 4.1 Overview of the intracellular oxidative mechanisms occurring 
when U937 cells interact with oxLDL 
OxLDL can induce a range of intracellular responses to U937 cells, by causing a rapid generation of 
intracellular oxidative stress through NOX-2 activation, oxidizing essential enzymes involved in 
metabolism, cell death mechanism or cellular defence. Alternatively oxLDL can induce the 
accumulation of intracellular cholesterol, causing prolonged ER stress and subsequent caspase 
activation. Both mechanisms result in either an apoptotic or necrotic cell death mechanism, 
contributing to the development of the necrotic core.  
 
Myeloperoxidase (MPO) was shown to not be involved in the U937 cell line oxidative 
stress mechanism (Figure 6.1), however, traditional sources of MPO include blood 
neutrophils (Sugiyama 2001) and lesional macrophages in atherosclerosis  
(Daugherty, 1994). Additionally, hypochlorite has been shown to be a common 
substituent in atherosclerotic plaque, suggesting that MPO is highly active within this 
site (Hazen 1997). Hypochlorite induced a significant loss of intracellular GSH, 
GAPDH activity and subsequent loss of cell viability in human monocyte-derived 
macrophages (HMDM) (Figure 6.1) (Schraufstätter 1990, Sugiyama 2004, Yang 
2012 B). Collectively, this indicates that although MPO was not present in the U937 
cells mechanism, once human neutrophils or lesional macrophages produce 
hypochlorite, it is capable of causing extensive oxidative damage to the cell resulting 
in a necrotic cell death (Yang 2012 B). 
 
Our research has provided strong evidence that NOX-2 is involved in the generation 
of intracellular superoxide in response to oxLDL and induces the cytotoxic effects as 
seen above (Figure 6.1). It has been shown that acute oxLDL toxicity is capable of 




induces THP-1 apoptosis with caspase activation (Baird 2004) while in HMDM and 
U937 cells, oxLDL causes an increase of oxidative stress and subsequent necrotic cell 
death without caspase activation (Figure 6.1) (Gieseg 2008, Gieseg 2010 B, Katouah, 
2015). However, the exact cause of this variation in acute oxLDL cytotoxicity 
remains unknown. It is unknown if oxLDL is solely inducing the activation of NOX 
oxidative stress, generating the intracellular oxidative stress or if oxLDL is causing a 
combination of oxidative induced damage and ER stress, resulting in cell death 
(Figure 6.1). Understanding the mechanisms of how oxLDL exerts its toxicity on a 
cell type allows for future research into prevention of cell death. Cell death causes 
constant inflammation of the arterial intima and subsequent development of the 
necrotic core. By reducing the oxLDL mediated radical generation, it may be possible 
to prevent the inflammatory events that lead to progressive macrophage recruitment 
and plaque growth. 
 
4.5 Future Research 
Future research should investigate the mechanism between NOX inhibition and the 
secondary source of oxidative stress. This could be achieved by incubating U937 cells 
with gp91ds-tat plus 7,8-NP and determine (through PI-cell viability and DHE assay) 
if the background oxidative stress is completely inhibited through 7,8-NP protection.  
There is a possible avenue to verify the trends seen in U937 NOX inhibition with 
other cell lines such as human monocyte derived macrophages (HMDM) or THP-1 
cells, to determine if what is observed is a cell line specific response. 
Another area that is yet to be explored is the link between the oxLDL-induced 
oxidative stress and the reduction in mitochondria membrane potential. Utilizing a 
different fluorescent dye would be beneficial to determine if the decrease in 
membrane potential is a result of oxidative damage or if the cell is undergoing a cell 
death mechanism. In vivo research could investigate the effect of higher GP91ds-tat 
concentrations (1-2µM) or the effect of ABAH on human plaque sections to 







This research confirms that oxLDL is inducing significant increase of intracellular 
oxidative stress, followed by a subsequent cell death in U937 cells. Myeloperoxidase 
did not contribute to the intracellular oxidative mechanism nor did MPO inhibitors 
protect the cells from dying an oxLDL-induced cell death. The research supports the 
hypothesis that NOX is the major source of oxidative stress in oxLDL induced U937 
cells and immune activated plaque sections. Further research into the mechanism of 
oxLDL cell death is required, including investigating possible additional sources of 
oxidative stress. Further research is required to rule out the mitochondria in the 
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